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ABSTRACT 
Risk profiles associated with many diseases are formed at a very early stage of 
development, which occur before birth. Exposure of the fetus to maternal 
psychological distress during pregnancy may alter fetal biology and thus predispose 
the fetus to subsequent illnesses such as childhood recurrent respiratory infections. 
This dissertation is part of the FinnBrain Birth Cohort Study, which recruited 3808 
families between years 2012–2015. This prospective cohort-based study followed the 
symptoms of anxiety and depression in mothers, partnership satisfaction and the 
occurrence of children’s recurrent respiratory tract infections from the 14th week of 
pregnancy until the child was two years old. Our aim was to investigate whether there 
was an association between maternal prenatal psychological distress and the 
occurrence of the child’s recurrent respiratory tract infections. In a smaller subset of 
the Cohort, we investigated the association of maternal prenatal psychological distress 
on cortisol production in 10-week-old children. We also investigated the relationship 
between genetic susceptibility to respiratory infections and the interaction between 
genetic susceptibility and maternal prenatal psychological distress. 
In this study, it was shown that in addition to the previously known risk factors 
(e.g. the number of siblings, shorter duration of breastfeeding), maternal prenatal 
psychological distress was associated with an increased risk for recurrent respiratory 
infections in children. In addition, we found that in children, whose mothers had 
prenatal psychological distress, had a reduced cortisol response in the stress test 
depending on if the child had a concomitant rhinovirus infection. Genetic variations 
in the IFI44L gene, part of the type I interferon pathway, associated with an increased 
susceptibility to respiratory infections and acute otitis media. Interleukin-6 gene 
variations were associated with an increased risk for recurrent respiratory infections. 
There was no interaction between these genetic predispositions and maternal stress 
during pregnancy, but sex differences were noted. 
This work provides new preventive strategies for recurrent upper respiratory 
tract infections in children and offers new insights into the interactions between 
stress and immune systems. 
KEYWORDS: children, cortisol, maternal prenatal stress, otitis media, recurrent 
respiratory tract infections, single nucleotide polymorphism   
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LAURA KORHONEN: Raskaudenaikainen stressi, geneettiset variaatiot ja 
toistuvat hengitystieinfektiot- FinnBrain-syntymäkohorttitutkimus 
Väitöskirja, 120 s. 
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Huhtikuu 2020 
TIIVISTELMÄ 
Sairauksien riskiprofiili voi muodostua jo ennen syntymää. Sikiön altistuminen äidin 
psykologiselle stressille raskauden aikana saattaa muuttaa sikiön biologiaa altistaen 
myöhemmille sairauksille kuten toistuville hengitystieinfektioille. 
Väitöskirja on osa FinnBrain-syntymäkohorttitutkimusta, johon on rekrytoitu 
3808 perhettä vuosina 2012–2015. Tässä prospektiivisessa syntymäkohortissa 
seurattiin äitien ahdistus- ja masennusoireita, parisuhdetyytyväisyyttä 14. raskaus-
viikolta siihen asti, kun lapsi oli kahden vuoden ikäinen. Myös tiedot lapsien 
toistuvista hengitystieinfektioista kerättiin. Tavoitteenamme oli tutkia äidin 
raskaudenaikaisen stressin (masennus–ja ahdistusoireilun) yhteyttä lapsen riskiin 
sairastaa toistuvia hengitystieinfektioita. Pienemmässä kohortin osajoukossa 
tutkimme äidin raskaudenaikaisen stressin vaikutusta 10 viikon ikäisten lasten 
kortisolin tuotantoon stressikokeessa. Tutkimme myös geneettistä alttiutta 
hengitystieinfektioille ja geneettisen alttiuden sekä äidin raskaudenaikaisen stressin 
yhteisvaikutusta. 
Tässä tutkimuksessa osoitettiin, että jo tunnettujen riskitekijöiden (esim. 
sisarusten lukumäärä, imetyksen lyhyempi kesto) lisäksi äidin raskaudenaikainen 
stressi oli yhteydessä lapsen suurentuneeseen riskiin sairastaa toistuvia hengitys-
tieinfektioita. Lisäksi havaitsimme, että lapsilla, joiden äideillä oli ollut raskaus-
aikana stressioireita, todettiin alentunut kortisolivaste stressikokeessa, mikäli 
lapsella oli samanaikainen rinovirusinfektio. Geneettiset vaihtelut tyypin I 
interferonivasteeseen liittyvässä IFI44L-geenissä lisäsivät alttiutta hengitys-
tieinfektioille ja välikorvatulehduksille. Interleukiini 6-geenin polymorfismi liittyi 
lapsen lisääntyneeseen riskiin sairastaa toistuvia hengitystieinfektioita. Näillä 
geneettisillä alttiuksilla sekä äidin raskaudenaikaisella stressillä ei todettu 
yhteisvaikutusta, mutta sukupuolieroja havaittiin. 
Tämä tutkimus tuo uutta tietoa lasten toistuvien hengitystieinfektioiden 
ennaltaehkäisyyn sekä tuo tietoa stressinsäätely- ja immuunipuolustusjärjestelmien 
välisen vuorovaikutuksen kehittymisestä. 
AVAINSANAT: kortisoli, lapset, toistuvat hengitystieinfektiot, välikorvatulehdus, 
yhden emäksen polymorfismi, äidin raskaudenaikainen stressi  
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1 Introduction 
Respiratory tract infections (RTIs) cause most of the morbidity among children 
under two years of age leading to a health and economic burden on society (Toivonen 
et al., 2016a; Tang et al., 2017; Fendrick et al., 2003). Approximately 10 % of all 
children suffer recurrent respiratory tract infections (RRIs). Children with RRIs need 
recurrent antibiotic treatments and undergo surgical procedures such as 
tympanostomy tube insertions and adenectomy (Toivonen et al., 2016a). The annual 
costs of children’s RTIs are estimated to be in a similar range as the costs of 
hypertension and greater than those of asthma (Fendrick et al., 2003). This is due to 
doctor visits, medical treatments and parents’ loss of workdays. It is also self-evident 
that children suffering from RRIs and acute otitis media (AOM) episodes have a 
lower quality of life (Jiang et al., 2013; Kujala et al., 2017). Additionally, the parents 
of children with RRIs often experience a decline in the their quality of life and are 
likely to spend significant amounts of time away from work (Jiang et al., 2013). 
Thus, these indirect costs of RRIs can even exceed the direct costs. 
In an era of personalized medicine, the unique host response to common 
infections and pathogens has been recognized. Although the majority of genetic 
variations does not cause diseases but rather creates personal traits, single nucleotide 
polymorphisms (SNP) explain a part of the unique response to pathogens and 
medication. SNPs involved in innate immunity may have an effect on younger 
children’s infections as adaptive and innate immunity matures during infancy. 
Adaptive immunity is supported by the mothers’ immunoglobulin G that is 
transferred from the mother transplacentally and in breast milk. Females and males 
differ in their innate immune responses, which implies that some sex differences in 
innate immunity responses may be encoded on the X chromosome (Klein and 
Flanagan, 2016). Transcriptional analyses have shown sex differences, for example, 
in the induction of type I interferon (IFN) responses and synthesis of 
proinflammatory cytokines (Klein et al., 2010). Still, surprisingly few published 
papers have addressed the possibility of sex-related vulnerabilities, while studying 
biological susceptibility to RRIs.  
In addition to a genetic predisposition to recurrent infections, the health of child 
depends on the characteristics of their early environment, such as factors related to 
Introduction 
 11 
family socioeconomic status or parental health and health behavior. Recently, it has 
been observed in epidemiological studies that also exposure to maternal 
psychological stress during gestation may influence immunity and the risk of 
recurrent infections, while the biological mechanisms behind these observed 
associations have not been fully studied (Henriksen and Thuen, 2015). One the most 
actively studied domains is the hypothalamic-pituitary-adrenal (HPA) axis. It has 
been suggested that alterations in the HPA axis functioning of the mother would play 
a role in bridging prenatal stress exposures to later offspring health outcomes (Bailey 
et al., 2003; Beijers et al., 2010; Beijers et al., 2014). A stress-related increase in 
maternal cortisol potentially increases fetal exposure to cortisol and subsequently 
affects the development of the fetus’ immune domains and the HPA axis (Merlot et 
al., 2008; Howerton and Bale, 2012; Xiong and Zhang, 2013). If the communication 
between the HPA axis and immune system is disrupted, changes in anti-viral immune 
responses may take place (Bailey et al., 2003; Webster and Sternberg, 2004). Bi-
directional communication between the neuroendocrine and immune systems plays 
a significant regulatory role in response to a viral infection (Bailey et al.,2003). 
During sensitive periods of fetal development, prenatal environmental events, such 
as exposure to maternal psychological distress and elevated cortisol levels, can have 
long term consequences on a child’s health (Xiong and Zhang, 2013). 
In a transgenerational, prospective and observational population-based birth 
cohort study, we first analyzed novel risk factors for RRIs in children aged from 12 
to 24 months. Furthermore, maternal psychological distress during pregnancy and 
the genetic variants of innate immunity and gene - environment interactions between 
the two were investigated. Since previous studies in which the effects of the child’s 
sex have been taken into account are few in number, the possibility of sexually 
dimorphic responses was investigated. More specifically, the influence of prenatal 
maternal psychological distress on child HPA axis function in the context of 
subclinical rhinovirus infection was studied. Finally, regarding the genetic variants 
of innate immunity, another independent population-based birth cohort (the Steps to 
the Healthy Development and Well-being of Children, STEPS) was used in 
combination with the FinnBrain Cohort to study specifically the role of Interferon-
induced protein 44-like (IFI44L) polymorphisms in the susceptibility to RTIs in early 
childhood. The effect of these polymorphisms on blood messenger RNA (mRNA) 
transcriptional profiles were further analyzed in a subset of children from the 
FinnBrain Cohort. 
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2 Review of the Literature 
2.1 Respiratory tract infections in children 
RTIs are the most common infectious diseases among infants and toddlers with 
significant morbidity and mortality (Toivonen et al., 2016a; Monto and Sullivan, 
1993; Wardlaw et al., 2006). Usually children have 6–8 RTIs per year, but it seems 
that boys have more RTIs than girls during the first years of life (Monto and U.B, 
1974). Recent studies have presented lower prevalence of RTIs, and Toivonen and 
colleagues evaluated 8847 RTIs in children under 2 years of age. Their average 
annual incidence was 5.9 RTIs/child (95% C.I. 5.7-6.1)(Toivonen et al., 2016b). 
RTIs present seasonally, and in the Northern Hemisphere, they occur predominantly 
during autumn and winter, while in tropical areas during the rainy season (Heikkinen 
and Järvinen, 2003). Most RTIs are caused by respiratory viruses circulating in the 
community. For example, viruses spread from siblings to younger children and from 
child to child in daycare. Rhinovirus is the most common cause of RTIs in children, 
followed by coronaviruses, influenza viruses, respiratory syncytial virus and 
parainfluenza viruses (Heikkinen and Järvinen, 2003; Toivonen et al., 2016b). 
Clinical presentation of rhinovirus infection can often be asymptomatic, and it does 
not cause long-term viral persistence in the respiratory tract. Respiratory viruses 
increase the susceptibility to secondary bacterial infections with several mechanisms 
like compromised physical and immunological barriers. There is also evidence of a 
synergistic effect between viruses and bacteria in the pathogenesis of respiratory 
infections (Bellinghausen et al., 2016).  
RTIs pose a substantial disease burden for individuals, as they are often 
complicated by AOM and antibiotic use is common, even in the pneumococcal 
conjugate vaccine era (Chonmaitree et al., 2016). Bronchiolitis and wheezing are 
also associated with RTIs and may lead to hospitalization and the development of 
childhood asthma (Jartti and Gern, 2017). Viral infections have been shown to be a 
prevalent risk factor for wheezing among children hospitalized before 3 years of age 
and the interaction between asthma and virus-induced inflammation may be 
synergistic rather than additive (Heymann et al., 2004). It has been reported that 10% 
of children under two years of age suffer from recurrent upper and lower RTIs 
(Toivonen et al., 2016a). 
Review of the Literature 
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2.2 Definition of recurrent respiratory infections 
Defining RRIs is a complex issue, as there is no clear consensus about how frequent 
infections should be considered as “recurrent” infections. Very different definitions 
of RRIs exist in the literature, and they can be generic or restrictive (Jesenak et al., 
2011). Studies have defined RRIs by the number of infection episodes per year. 
Usually six or greater number of respiratory infections per year are considered as 
recurrent infections or one or more respiratory infections per month involving the 
upper airways from September to April (Jesenak et al., 2011). One definition is the 
occurrence of eight or more documented airway infections per year in children up to 
three years of age or of six or more in children older than three years of age, assuming 
that the child has no diagnosis of an underlying long-term illness that predisposes to 
infections (Schaad et al., 2015). In a birth cohort study, STEPS, 1089 children were 
followed to 2 years of age for respiratory infections by a daily symptom diary. In all, 
10% of children with the highest number of annual respiratory illness days were 
defined to have RRIs. These children had a median of 9.6 acute respiratory infections 
per year (Toivonen et al., 2016a). 
Other definitions have been more focused on diagnoses, for example, acute otitis 
media (AOM) or lower respiratory infections (Nokso-Koivisto et al., 2002; de 
Benedictis and Bush, 2018). As for the frequency of infections, it has been defined, 
that three AOM episodes within 6 months or four episodes within 12 months stand 
for recurrent infections (Schaad et al., 2015). RRIs may overlap with each other or 
be prolonged, which makes it difficult to report the exact number of infections, or 
for example, AOM diagnoses. Between individuals, the severity of symptoms and 
complications vary as some children may have several RTIs without developing 
AOM, whereas others have several antibiotic treatments due to bacterial 
complications of RTIs.  
2.3 Risk factors and morbidity of recurrent 
respiratory infections 
Parental smoking during and after pregnancy, a lower socioeconomic status of the 
family, a shorter duration of breastfeeding, a greater number of siblings and outside-
home daycare have all been identified as environmental risk factors for RTIs in 
children and are noted in Table 1 (Cohen, 1999; Schuez-Havupalo et al., 2017). 
These risk factors can be independent but are more likely to occur simultaneously 
forming a compounded effect of environmental and sociocultural exposures and 
therefore can be modifiable. These risk factors highlight the importance of 
preventive healthcare. Indeed, children’s health is linked to their parents' physical 
Laura Korhonen 
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and emotional health, social conditions and child-rearing practices (Schor and 
American Academy of Pediatrics Task Force on the Family, 2003).  
Table 1.  Studies assessing risk factors for respiratory tract infections in children. 
Risk factor for 
RTIs OR (95%CI) 
Study 
population N 
Age 
years Study 
Duration of breast 
feeding > 3 
months 
0.5 (0.3–0.9) 273 < 3 Nicolai et al., 
2017 
 0.96 (0.93–0.99) 367 ≤ 1 Chonmaitree et 
al., 2016 
Number of 
siblings 
3.0 (1.8–5.2) 273 < 3 Nicolai et al., 
2017 
 1.07 (1.01–1.14) 367 ≤ 1 Chonmaitree et 
al., 2016 
Outside-home 
daycare 
1.74 (1.44–2.11) 367 ≤ 1 Chonmaitree et 
al., 2016 
Parental smoking 1.74 (1.06–2.87) 1129 < 9  Jedrychowski and 
Flak, 1997 
 2.3 (2.0–4.2) 273 < 3 Nicolai et al., 
2017 
Lower 
socioeconomic 
status 
1.5 (1.1–2.0) 5989 ≤ 5  Bor et al., 1993 
Respiratory tract infection (RTI) 
AOM is one of the most common childhood infectious diseases and is often preceded 
by a respiratory infection. RRIs and recurrent or prolonged otitis media infections 
overlap with each other. Duration of breastfeeding, out-of- home day care and 
parental smoking were identified as significant risk factors for AOMs in the meta-
analysis by Uhari and colleagues. The authors implied that consideration should be 
given to these risk factors to reduce AOM episodes and antibiotic treatments in 
children (Uhari et al., 1996). Regarding a child’s own genetic traits, some of the 
children may be more vulnerable than others to environmental risk factors regarding 
RTIs and RTI-related morbidity. In a study including two birth cohorts, the 17q21 
risk SNPs and, in particular, rhinovirus- derived  early respiratory wheezing 
proceeded the development of asthma in childhood (Caliskan M et al., 2013). SNPs 
at the 17q21 locus have been associated in retrospective reports with respiratory 
illnesses in early life. Reports have shown that the associations between 17q21 
region genetic variants and RTIs or asthma are further enhanced among children 
exposed to environmental tobacco smoke (Smit et al., 2010). 
Review of the Literature 
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2.4 Pathophysiology and genetics of recurrent 
respiratory infections 
Children under two years of age have a predisposition to frequent RTIs, as the innate 
and adaptive immune responses are immature, and maternal antibodies derived 
through the placenta decrease (Tregoning and Schwarze, 2010). Viral infections 
activate the innate immune system as a first line defense in minutes. The key function 
of the innate immunity is to detect viral components such as viral RNA or DNA or 
viral intermediate products with pattern recognition receptors (PRRs) such as Toll-
like receptors (TLRs). Infected cells produce IFNs and other pro-inflammatory 
cytokines, for example, tumor necrosis factor alpha (TNF) and interleukin-6 (IL-6) 
to prevent viral invasion or replication before more specific protection by the 
adaptive immune system is generated (Koyama et al., 2008). 
A single-nucleotide polymorphism (SNP) refers to a genetic polymorphism 
based on a single base pair exchange in adenine (A), thymine (T), cytosine (C) or 
guanine (G) causing DNA sequence variation. Almost all common SNPs have only 
two alleles, for example a C and G. In order for such a variation to be defined as a 
SNP, the less common allele must occur in the population at a frequency of at least 
1%. SNPs represent around 90% of the differences among the genomes of human 
individuals and occur in coding sequences of genes, non-coding regions of genes or 
in the intergenic regions between genes. The most common allele is named as a 
“major” or “wild type” and the less frequent allele as “minor”, which frequency is 
often reported as minor allele frequency (MAF). Although the majority of variations 
in the DNA sequences does not cause diseases but rather creates personal traits, 
SNPs explain part of the unique response to pathogens. Individual responses to 
common pathogens vary, and SNPs involved in innate immunity may have an effect 
on younger children’s infections. Genetic variants affecting the function of the innate 
immune system have been linked to infection susceptibility particularly in young 
children. Factors of innate immunity with genetic variation include, for example, 
PRRs, such as the family of TLRs (Mittal et al., 2014) and mannose-binding lectin 
(MBL) (Cedzynski et al., 2004; Eisen, 2010). These PRRs recognize pathogens or 
specific microbial structures leading to the induction of inflammatory pathways in 
cells. IFNs are secreted by infected cells after recognition of microbial products, for 
example, viral components such as viral RNA or DNA,  by PRRs (Ivashkiv and 
Donlin, 2014). IFNs promote antigen presentation and NK cell functioning, and this 
leads to transcription of interferon-stimulated genes (ISGs) in infected cells. 
Interferon-induced protein 44-like (IFI44L) protein belongs to the group of proteins 
encoded by ISGs. IFI44L is transcriptionally induced by IFNs and has antiviral 
specificity (Schoggins et al., 2011). Cytokines participate in cell signaling involved 
in the innate and adaptive immunity and play a role in children’s 
immunocompetence. Polymorphisms in TNF, IL-6 and IL-10 genes have been 
Laura Korhonen 
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reported to affect the susceptibility to RTIs (Rose-John et al., 2017; Emonts et al., 
2007; Revai et al., 2009). Revai et al, studied 242 children, who were followed over 
2689 patient-months and genotyped. 1235 RTIs occurred, and 392 (32%) were 
complicated by AOM. Children, who had an IL-6 (-174) gene variant, had a higher 
susceptibility to RTIs during the study period and were more likely to meet 
established otitis susceptibility criteria than children with the wildtype gene. The 
presence of a TNFα (-308) polymorphism was associated with an increased risk for 
AOM after an episode of respiratory tract infection (Revai et al., 2009).  
Moreover, few genome-wide association studies (GWAS) have been performed 
for childhood infections. A study by Tian et al suggested associations between genes 
of innate immunity and common infections such as tonsillitis and middle ear 
infections. Genes involved in embryonic development also associated with 
infections, for example, the missense mutation (rs72646967-C, N397H) in TBX1, 
which is essential for inner ear development associated with a lower risk of  AOMs  
(Tian et al., 2017). Furthermore, individuals have sex-specific genetic traits and 
innate immunity responses may be encoded on the X chromosome (Klein and 
Flanagan, 2016). Male sex has been found to be risk factor for respiratory tract 
infection recurrence (Anders et al., 2015). 
2.5 Prenatal stress 
Maternal stress is a common environmental risk factor for the fetus, as stress is 
increasingly becoming a common part of our everyday living. More than a quarter 
of people in a developed country reported daily stress levels to be high or severe  
(Connor et al., 2019). Prenatal maternal stress is associated with later mental health 
problems of offspring during adulthood such as depression and personality disorders 
(Thompson et al., 2001; Brannigan et al., 2019). The Developmental Origins of 
Health and Disease (DOHaD) theory is applicable in psychiatry/psychology, because 
the environment of early childhood plays a role in the determinants of mental health 
(O’Donnell and Meaney, 2017). Barker and his colleagues made the first 
observations that a lower birth weight is a risk factor for the development of 
cardiovascular and metabolic diseases such as arterial hypertension, coronary heart 
disease, obesity and type 2 diabetes (Barker and Osmond, 1986). The hypothesis was 
that birth weight is an indicator of intrauterine conditions and that variation in fetal 
growth reflects variation in how the fetus adapts to subsequent extrauterine life. 
Additionally, according to this theory, the set point of physiological and metabolic 
responses is programmed during gestation. Later, epidemiological studies showed 
that, during sensitive periods of fetal development, prenatal environmental events 
are important factors for shaping the risk for morbidity later in life together with 
genetic risks and postnatal exposures (Daskalakis et al., 2013).  
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The central nervous system, autonomic nervous system, neuro-endocrine, HPA 
axis, cardiovascular and immune systems have their highest plasticity during early 
development, when the organ systems are still immature making them vulnerable to 
the influences of prenatal stress exposure (Bale, 2015; Griffiths and Hunter, 2014; 
Harris and Seckl, 2011;Meaney et al., 2007; Seckl, 2004; Xiong and Zhang, 2013). 
Maternal prenatal stress has been linked with alterations in HPA axis function, 
changes in glucocorticoid receptor sensitivity, changes in proteins and 
neurotransmitters involved in neuronal development and function in the central 
nervous system of the fetus (Van den Bergh et al., 2017). These changes lay the 
foundation for susceptibility to somatic diseases and mental health problems in their 
interactions with genetic liabilities and postnatal challenges (Van den Bergh et al., 
2017). During embryonic and fetal development, tissues and organs are created in a 
chronological sequence. This leads to specific time points in which some cell 
components become more sensitive than others. The recognition of these windows 
of vulnerability is fundamental considering the complexity of the fetal development 
(Veru et al., 2014). The definition of prenatal stress has included various sources of 
stress, for example, the couples' relationship satisfaction and stressful life 
events, daily hassles and natural disasters such as the 1998 Quebec ice storm (Beijers 
et al., 2010; Henriksen and Thuen, 2015; Veru et al., 2015). Maternal psychological 
distress as source of prenatal stress has comprised maternal symptoms of depression, 
anxiety and pregnancy-specific anxiety. These different sources of stress have 
resulted in the biological heterogeneity and variety among the phenotypes of prenatal 
stress (Mustonen et al., 2018). For example, depression and anxiety may occur 
through different biological pathways.  
2.6 Prenatal maternal psychological distress and 
recurrent respiratory infections 
As previously stated, the psychological well-being of the mother affects the child's 
health. Most the studies showing a link between the maternal psychological health 
and a child’s RTIs have focused on the postnatal period (Horwitz et al., 1993; K 
Louhi-Pirkanniemi et al., 2004). Nevertheless there are few studies demonstrating a 
link between prenatal maternal psychological distress and infection related outcomes 
(Marion Tegethoff et al., 2011; Nielsen et al., 201; Beijers et al., 2010; Henriksen 
and Thuen, 2015). In a Danish nation-wide cohort, Nielsen et al found, an association 
between maternal prenatal stress, which is defined as maternal exposure to a stressful 
life event during pregnancy or in the 3-year period before conception, and the risk 
for hospitalizations because of infectious diseases during childhood. Beijers and 
colleagues found that maternal pregnancy-related anxiety by self-reporting as well 
as by mothers’ circadian cortisol from saliva samples predicted a significant 
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proportion of variance in the offspring respiratory illness during the first year of life. 
In addition, maternal scoring in The Pregnancy-Related Anxiety Questionnaire 
(PRAQ) first subscale; being the Fear of Giving Birth, was related to an offspring’s 
greater use of antibiotics during their first year of life (Beijers et al., 2010). During 
pregnancy, the parental relationship is often the main source of psychological 
support for both adults. Thus, the parental relationship can be viewed as one of the 
fundamental sources of stress regulation. In the Norwegian Mother and Child Cohort 
Study 2015, including 100,027 children, prenatal maternal relationship 
dissatisfaction and stressful life events were significantly associated with an 
increased frequency of infectious diseases in the offspring after controlling for the 
most important confounding factors (Henriksen and Thuen, 2015).  
Although it is impossible to completely disentangle and distinguish the 
behavioral and genetic aspects from fetal programming, maternal psychological 
distress during pregnancy is reportedly an independent risk factor for respiratory 
illness and infectious disease hospitalization  in the offspring (Beijers et al., 2010; 
Henriksen and Thuen, 2015; Nielsen et al., 2011). Indeed, prenatal and early life 
stress exposures have potential effects on the development of the child’s immune 
system. 
2.7 Prenatal maternal psychological distress and 
offspring's immunity 
Human and animal studies do suggest that maternal prenatal stress has long-lasting 
effects on immunity. In addition to infection-related outcomes, maternal long-term 
prenatal psychological stress is associated with childhood asthma and allergy as well 
as inflammatory bowel disease (Andersson et al., 2016; Aujnarain et al., 2013). 
Although knowledge on the possible mechanisms underlying these relations is 
limited, several potential mechanisms involved have been proposed (Beijers et al., 
2014).  
The stress response is mainly mediated through two physiological mechanisms, 
the sympatho-adreno-medullary (SAM) system and the HPA axis. The adrenal 
cortex produces cortisol and cortisol can cross the placenta at high levels. The access 
of glucocorticoids to the fetus is regulated by the placental enzyme 11-β-
hydroxysteroid dehydrogenase type 2 (11βHSD2). Maternal psychological stress 
during pregnancy can lead to secretion of catecholamines, which can lead to a 
decrease in the activity of 11βHSD (O’Donnell and Meaney, 2017). Maternal plasma 
cortisol levels have been shown to correlate with fetal cortisol levels, and maternal 
cortisol accounts for about 40% of the variance in fetal cortisol concentrations (Gitau 
et al., 1998). The relationships between the neuroendocrine and immune systems are 
mediated by hormones, neurotransmitters as well as cytokines. Maternal chronic 
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stress is related to a less well-functioning immune system, higher susceptibility to 
infections and generally a lower quality of physical health with altered health 
behaviors that includes eating, sleeping, and exercise (Beijers et al., 2014). 
Psychosocial stress has also been related to unbalances in the intestinal microbiota 
(Beijers et al., 2014). 
During sensitive periods of fetal development, maternal stress hormones can 
affect the development of the fetal immune system or other physiological systems 
that regulate the immune response such as the HPA axis (Merlot et al., 2008; 
O’Donnell and Meaney, 2017). These changes may be due to gene-environmental 
interactions and alterations in epigenetic pathways. The ontogeny of the immune 
system consists of a series of coordinated and sequential processes. During fetal 
development, gene expression is constantly altered modifying the profile of receptor 
molecules in all cells and their responsiveness to environmental influences including 
hormones, cytokines and toxicants (Munitic et al., 2004). HPA axis hormones can 
have an effect on the gene expression profile, and when the developing immune 
system is exposed to excess glucocorticoids during the critical periods, even a 
permanent alteration of physiology and later health can take place (Xiong and Zhang, 
2013). As mentioned before, the specific time frames are very important during 
ontogenesis and studies should state these windows of vulnerability (Merlot et al., 
2008; Veru et al., 2014). Regarding to prenatal maternal psychological distress and 
its effects on infant’s immunity, the findings are heterogeneous. This is partly due to 
the varying definitions of prenatal stress and partly due to the fact that not all studies 
have taken in to account the time of the stress exposure during pregnancy. Also, 
animal studies have shown that chronic maternal stress during pregnancy has a 
different effect on offspring immunity compared to one-time exposure. 
2.7.1 Animal studies 
Animal studies have shown that prenatal stress affects the development of the fetal 
immune system (Bellinger et al., 2008; Couret et al., 2009). Findings are incoherent, 
as the duration of the prenatal stressor and/or time of stress exposure varies. Also, 
different types of stressor have been used, usually being either neurogenic with 
exposure to light, electric shocks or saline injection, for example, or psychogenic 
with housing that is unfamiliar conspecific, crowded or having a resident-intruder 
confrontation (Veru et al., 2014). Depending on the type of stressor, the pregnant 
animal's nervous system processes these harmful stimuli differently and produces a 
distinctive neuroendocrine response (Veru et al., 2014). This response is modulated 
by pregnancy-related changes in the mechanisms of the neuroendocrine immune 
response. IL-6 has been suggested to be one of the mediators in the programming of 
immune ontogeny. It has been shown that, during mid-gestation, IL-6 is capable of 
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crossing the placenta (Dahlgren et al., 2006). Mediators of the neuroendocrine-
immune system can work directly or indirectly (e.g., through placental changes). 
Findings are different between the species as primates, for example, are the only 
species that produce placental corticotropin releasing hormone (CRH) during 
pregnancy (Merlot et al., 2008). Also, sex of the offspring have an effect on outcomes 
(Veru et al., 2014). Overall, prenatal maternal stress can result in maladaptive 
programming of immune function, as prenatal maternal stress increases production 
of Th2 relative to Th1 cytokines that dampen cellular immunity (Veru et al., 2014). 
Signs of immune system formation in animal studies include decreased cytotoxicity 
of natural killer (NK) cells and decreased cytokine secretion (Kay et al., 1998) (Coe 
et al., 2002). Couret et al. studied the consequences of a repeated social stress applied 
during late gestation of the pregnant gilt on the immune system and HPA axis 
activity of the piglets from birth to two months of age. Prenatal maternal stress 
decreased the total numbers of white blood cells, lymphocytes and granulocytes, the 
CD4 (+)/CD8(+) T cell ratio and lipopolysaccharide -induced TNF production. 
There is also evidence that the effects of prenatal stress on the immune system extend 
into adulthood (Merlot et al., 2008). 
2.7.2 Human studies 
Although epidemiological studies have proven that there is a link between prenatal 
stress and alterations in an infant’s immunity, studies on biological mechanisms 
behind this association are rare. The most frequently mentioned biological 
mechanisms are: 1) immunomodulation due to modification of ontogeny of the 
immune system and 2) changes in communication between the HPA axis and 
immune system. Emerging data additionally suggests that alterations in gut 
immunity and microbial composition in the offspring as well as in the mother play a 
role (Figure 1).  
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Figure 1.  Maternal prenatal stress related to the current hypothesis of the effects on placenta and 
fetus. Suggested mediating mechanisms are the developmental changes in the immune 
system and in the HPA axis. Also, alterations in gut immunity and microbial composition 
in the offspring as well as in the mother are associated with maternal prenatal stress. 
In a subsample of 403 term infants from the Canadian Healthy Infant Longitudinal 
Development (CHILD) cohort, infants born to mothers with pre- and postnatal 
depressive symptoms had significantly lower median secretory Immunoglobulin A 
(sIgA) concentrations than those in the reference group after controlling for 
breastfeeding status, infant age, antibiotics exposure and other covariates. Secretory 
IgA plays a critical role in infant gut mucosal immunity (Kang et al., 2018). In 
another study, the development of the infant intestinal microbiota was followed until 
4 months of age in a healthy cohort of 56 vaginally born Dutch infants. Results 
suggested that maternal prenatal stress, measured by either self-reports or elevated 
basal maternal salivary cortisol concentrations or both, was associated with the 
infants' microbiota composition. Infants of mothers with high cumulative stress (i.e., 
high self-reported stress and high cortisol concentrations) during pregnancy had 
significantly higher amounts of proteobacterial groups and lower number of lactic 
acid bacteria, which are characteristics of a potentially increased level of 
inflammation. Furthermore, this aberrant colonization pattern was related to an 
increased number of maternally reported infant gastrointestinal symptoms and 
allergic reactions (Zijlmans et al., 2015). 
The Project Ice Storm included mothers that were pregnant during the 1998 
Quebec ice storm. Blood samples from 37 of their children, when they were 13 years 
old, were obtained to measure cell population percentages and mitogen-induced 
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cytokine production. They found that the mothers' objective degree of prenatal 
maternal stress exposure significantly predicted reductions in total and CD4+ 
lymphocyte proportions; increases in TNF-α, IL-1β and IL-6 levels, and an 
enhancement of the Th2 cytokines IL-4 and IL-13. Sex and timing of exposure 
during gestation were also associated with some outcomes (Veru et al., 2015). They 
also showed that DNA methylation meditates the effect of exposure to prenatal 
maternal stress on cytokine production, that favors  a Th2 shift (Cao-Lei et al., 2016). 
The Urban Environment and Childhood Asthma Study (N = 557 families) 
demonstrated that prenatal stress was associated with altered innate and adaptive 
immune responses in cord blood mononuclear cells suggesting stress-induced 
perinatal immunomodulation (Wright et al., 2010). In a small prospective study of 
27 mother-newborn dyads, the authors found a significant, independent and linear 
effect of pregnancy-specific stress on newborn leukocyte telomere length that 
accounted for 25% of the variance (Entringer et al., 2013). 
Activation of the HPA axis is an important regulatory mechanism for the 
inflammatory response to an infectious challenge. Almost all immune cells have 
receptors for HPA hormones (Glaser and Kiecolt-Glaser, 2005). In contrast to the 
traditional view of glucocorticoids as immunosuppressant hormones, they are more 
accurately conceptualized as immunomodulatory hormones that can both stimulate 
as well as suppress immune function (McEwen, 2018). Huda et al found an 
association of pain-induced cortisol responsiveness with thymic function and 
vaccine responses in 1-to -15-week-old infants compromising 153 male infants and 
153 female infants and showed that cortisol responsiveness was negatively 
associated with thymus size (measured by ultrasound)  at all ages (P < 0.01) in boys. 
Cortisol responsiveness was negatively associated with naive helper T-cell 
concentrations in both sexes at both 6 and 15 weeks of age (Huda et al., 2019). 
2.8 Prenatal maternal psychological distress: 
effects on offspring's HPA axis function 
Psychosocial stress triggers a series of behavioral, neural, hormonal and molecular 
responses that are useful for survival that allow appropriate adaptation during a time 
frame (Zannas and Chrousos, 2017). A primary actor of the stress response is the 
HPA axis, which is activated by hypothalamic secretion of corticotropin-releasing 
hormone (CRH) and arginine vasopressin in the brain leading to adrenal secretion of 
glucocorticoids in the systemic circulation. At the molecular level, the effects of 
HPA axis activation and glucocorticoid signaling are largely mediated by the 
glucocorticoid receptor, a ligand-dependent transcription factor that drives the 
genomic actions of glucocorticoids in essentially all of body tissues (Zannas and 
Chrousos, 2017). In animal models of prenatal stress, glucocorticoid exposure, both 
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endogenous and exogenous, influences the development of the fetal HPA axis 
function, and this in turn leads to adaptation at every level of development from 
cellular to behavioral (Cottrell and Seckl, 2009; Harris and Seckl, 2011). According 
to the fetal programming hypothesis, glucocorticoids transmitted from mother to 
fetus during gestation communicate useful information about the external world, and 
this information is used for adaption, survival and success in the postnatal 
environment (Bateson et al., 2004).  
In a systematic review by Mustonen et al., associations between maternal 
prenatal self-reported symptoms of different types of prenatal psychological distress 
and hair cortisol concentrations across pregnancy were shown. The existing data 
implied that in a population with low levels of self-reported prenatal psychological 
distress, the associations with hair-derived cortisol concentrations were rather weak, 
but this association might be strengthened when studying populations with a greater 
variance in psychological distress and a higher frequency of elevated levels of 
psychological distress (Mustonen et al., 2018). It might be that there is not a clear 
correlation between self-reported questionnaire scores on maternal prenatal stress 
and cortisol concentrations in blood, saliva, hair or urine. Behavioral phenotypes 
may have different biological pathways. Still, self-report assessments of prenatal 
maternal psychosocial stress can be predictors of the future health of the child and 
may correlate well with biological measures. A study by Kane et all. with 448 
women showed that higher mean levels of pregnancy-specific anxiety over the 
course of pregnancy predicted higher maternal saliva cortisol traits compared to 
lower pregnancy anxiety (Kane et al., 2014). Moreover, chronicity of depressive 
symptoms seems to be related to elevated hair cortisol levels during pregnancy 
(Mustonen et al., 2019). 
2.8.1 Animal studies 
In animal models, high maternal cortisol levels have been primary mediators in 
programming of the offspring’s HPA function (Kapoor et al., 2006). In rats, maternal 
prenatal stress and high fetal corticosterone levels cause downregulation of fetal 
glucocorticoid and mineralocorticoid receptors and impair the HPA axis feedback 
control during both infancy and adulthood. The impairment in this HPA axis activity 
can be prevented by maternal adrenalectomy and mimicked by administration of 
glucocorticoids (Weinstock, 2005).  
Animal models do suggest that sex hormones modulate the effect of stress in 
reprogramming of the HPA axis. Previous studies have shown that glucocorticoid 
levels are higher in females than in males after HPA axis stimulation (Kudielka and 
Kirschbaum, 2005; Yoshimura et al., 2003). Animal studies have convincingly 
proven that estradiol affects the functioning of the HPA axis and has modulatory 
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effects on mineralocorticoid and glucocorticoid receptors (Kudielka and 
Kirschbaum, 2005; Viau and Meaney, 1991; Carey et al., 1995; Peiffer et al., 1991). 
By binding to estrogen-responsive elements on the CRH gene, estradiol may directly 
enhance CRH gene transcription (Gray et al., 2017). Androgens have specific and in 
partially opposite effects on HPA axis regulation, but it should be taken in to account 
that testosterone can be metabolized to estrogen by aromatization in both nervous 
and peripheral tissues and thus have estrogen-like effects (Kudielka and Kirschbaum, 
2005;Viau and Meaney, 1996; Chowen et al., 1990). 
Less severe protocols of prenatal stress result in a longer duration of 
corticosterone recovery after acute stress in adult females but not in adult males in 
rodents (Gray et al., 2017; Weinstock et al., 1992; McCormick et al., 1995). After 
more severe prenatal stress, adult male and female rodents show a longer duration of 
corticosterone secretion when exposed to acute stress (Gray et al., 2017; Maccari et 
al., 1995). This suggests that females are sensitive to less severe prenatal stress, 
whereas males require more severe prenatal stress to reprogram the HPA axis (Gray 
et al., 2017). 
2.8.2 Human studies 
The fetus is exposed to elevated levels of endogenous glucocorticoids in conditions 
when the levels of glucocorticoid are elevated in the mother due to stress or when 
the placental 11βHSD barrier decreases. During normal pregnancy, glucocorticoid 
concentrations in the maternal circulation are markedly higher than those in the fetal 
circulation (Benediktsson et al., 1997). During human pregnancy, the expression and 
activity of 11βHSD steadily increases as gestation progresses, and then decreases 
near term (at 38–40 weeks) (Schoof et al., 2001; Xiong and Zhang, 2013). Also, 
increased maternal cortisol concentrations may rise placental CRH concentrations. 
The placenta synthesizes and releases large amounts of CRH into the maternal and 
fetal circulations. Placental CRH concentrations have been related to impaired fetal 
growth (Beijers et al., 2014; Wadhwa et al., 2004). Studies have shown that adverse 
fetal programming may occur very early in pregnancy, even before neuroendocrine 
systems have developed and not only on or near birth (Speirs et al., 2004). The stress 
response is mediated also by the sympatho-adreno-medullary pathway, which is 
called the SAM system. Adrenaline is often associated with an acute stress, whereas 
noradrenaline is released to stabilize the stress response (Beijers et al., 2014; 
Sapolsky et al., 2000). Catecholamines may influence both the placenta and the fetus. 
A mother’s elevated  catecholamines concentrations lead to constriction of placental 
blood vessels, a decreasing fetal supply of nutrients and oxygen and elevated fetal 
catecholamine concentrations (Beijers et al., 2014). Also catecholamines may down-
regulate human placental 11βHSD  during gestation (Schoof et al., 2001). Studies on 
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psychosocial stress and catecholamine levels in pregnancy are few in number. The 
study of Petraglia and colleagues did not find a significant relationship between 
psychosocial stress and catecholamine levels in pregnant women at 28 gestational 
weeks (gwks) (Petraglia et al., 2001).  
Many effects of in utero exposure to maternal stress on offspring development 
are believed to manifest as hyperreactivity or hyporeactivity due to alterations in the 
infant’s HPA axis (Giesbrecht et al., 2017). Relatively few human studies with high 
quality on cortisol measurements and appropriate numbers of controls for potential 
confounding variables in statistical analyses have assessed the associations between 
prenatal cortisol exposure and children’s HPA axis function (Giesbrecht et al., 2017). 
Despite the high quality of these studies, the results are heterogeneous. Three studies 
reported higher cortisol levels and hyperreactivity of the HPA axis after prenatal 
maternal psychological distress exposure (Davis et al., 2011; Gutteling et al., 2005; 
Gutteling et al., 2004). One reported higher cortisol levels in offspring but a blunted 
response of  the HPA axis in a stress test (O’Connor et al., 2013). Two studies found 
no association (de Weerth et al., 2013; Tollenaar et al., 2011). Possible factors 
explaining the differences in the results, such as the timing of the maternal cortisol 
measure, varied in both within the day and within pregnancy measurements. Also, 
there were differences in the methods on how the cortisol exposure was measured. 
When saliva cortisol samples are collected over time, the area under the curve (AUC) 
can be used, and it provides insight into the interpretation of the derived parameter 
(Fekedulegn et al., 2007).  AUCi is derived as the area under the curve above the 
baseline value minus the area below the baseline value (Fekedulegn et al., 2007). 
Some studies have used the cortisol awakening response, which is the change in 
cortisol concentration that occurs in the first hour after waking in morning and in 
some studies cortisol concentrations from the amniotic fluid was used. Another 
difference was that the type of infant stressor varied. It should also be noted that not 
all effects of maternal psychological stress on the fetus and child are mediated by 
cortisol.  
2.9 Gene-Environment interaction  
Although in a modern era of medical research, the GWAS have become more 
common because of cost reductions, the identified variants explain only a small 
proportion of the heritability of many diseases. This unexplained heritability could 
be partly due to the gene-environment (GxE) interaction (Thomas, 2010). The gene 
(or genotype)–environment interaction, in its simplest terms, is the phenomenon of 
two different genotypes responding to environment exposures in different ways. 
Sometimes, sensitivity to environmental risk factors for a disease are inherited rather 
than the disease itself and that is why GxE studies can be considered to be related to 
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fetal programming. Through GxE analysis, it is possible to find subpopulations that 
are most susceptible to prenatal environmental events and are at risk for morbidity 
later in life. There have been arguments that GxE studies provide more precise 
targets to improve public health compared to traditional epidemiological studies 
(Hutter et al., 2013). There is some evidence that in healthy general populations, the 
mild elevations of maternal stress and cortisol might be advantageous to the fetus 
and offspring (DiPietro et al., 2006; Doyle et al., 2015). Negative effects of prenatal 
stress and cortisol exposures are most consistently observed when high cortisol 
exposures occur early during early pregnancy but potentially also very low levels of 
maternal prenatal stress can be harmful to the fetus (Giesbrecht et al., 2017; DiPietro, 
2012).  
New tools for studies have been the development of biological response markers 
for assessment of exposure including gene expression, transcriptomic signatures and 
DNA methylation profiles (McAllister et al., 2017; Thomas, 2010). Publishing 
negative findings is helpful, because this allows researchers to avoid repeating failed 
experiments (Hutter et al., 2013). As we learn more about the effects of early 
environmental exposures on the developing fetus, new opportunities for disease 
prevention are created. Knowledge about the mechanisms of disease susceptibility 
will help us to better understand the mechanisms of disease formation. Observations 
of GxE interactions can lead to important policy implications on environmental 
health standards and on to the targeting of interventions and treatment (Hutter et al., 
2013). 
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3 Aims 
The main aim of this work was to assess the relationship between maternal prenatal 
psychological distress and the risk for RTIs in children up to two years of age. The 
first objective was to assess the relationship between maternal prenatal stress and the 
risk for RRIs in children. We further studied if the exposure to maternal prenatal 
psychological distress was associated with the infant HPA axis reactivity in response 
to an acute stressor. Furthermore, we studied the association between genetic 
variants of innate immunity and the susceptibility to RTIs in early childhood in two 
independent birth cohorts. We investigated GxE interactions between genetic 
variants of innate immunity and maternal psychological distress with the clinical 
outcome of RRIs. Lastly, we aimed to investigate the presence of sexually dimorphic 
responses in the studied associations. Specifically, the aims were: 
1. To assess the relationship between maternal prenatal psychological 
distress comprising of depression and anxiety symptoms and relationship 
quality and the risk of RRIs in children up to two years of life.  
2. To investigate whether maternal prenatal psychological distress is 
associated with 10-week-old infants HPA axis reactivity, and whether this 
association is different in the presence of a subclinical rhinovirus infection 
that challenges the immune system.  
3. To determine the association of IFI44L polymorphisms rs273259 and 
rs1333969 with rates of RTIs, AOM episodes and antibiotic treatments 
during the first two years of age. The effect of these IFI44L gene 
polymorphisms on blood messenger RNA (mRNA) transcriptional 
profiles were further analyzed in a subset of children. 
4. To investigate the association of preselected genetic variants (IL6, IFI44L, 
IL10, IFIH1, MBL2, IL17A, TLR4, TLR2, IL4 and TNF) reportedly 
affecting the function of innate immune system with the clinical outcome 
of RRIs and to test a GxE hypothesis whether the risk for recurrent 
respiratory infections is dependent on both the genetic variants and in 
utero exposure to maternal psychological distress.  
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4 Materials and Methods 
4.1 Study design 
This work was carried out as part of transgenerational prospective observational birth 
cohort study: The FinnBrain Birth Cohort Study (www.finnbrain.fi)(Karlsson et al., 
2018). The questionnaire data and biological sample collection time points and 
procedures are presented in Table 2. The research questionnaires were either mailed 
to the participants or could be filled out online according to each participant’s choice. 
Recruited women gave birth at the Turku University Hospital in the Hospital District 
of Southwest Finland and after delivery, the umbilical cord was clamped, and blood 
from the umbilical cord vein was obtained for genetic analyses. The FinnBrain Birth 
Cohort Study visits at 3 months of age were performed in the research facilities. 
During the study visit, a pediatric examination was performed, and a blood sample 
was taken from the children as well as a nasopharynx/nasal swab. Five saliva cortisol 
samples were collected, at the beginning of visit and 0, 15, 25, and 35 minutes after 
the stressor.  
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Table 2. The questionnaire data and biological sample collection time points. 
 Hypothesis 
Prenatal 
psychological 
distress 
exposure 
Sample 
collection 
at birth 
Study 
visit, 
child 3 
months 
Recorded 
outcomes, child 
12 or 24 months 
Study  
I 
Maternal 
prenatal 
psychological 
distress (PD) 
independently 
increases the 
risk of RRIs 
Questionnaires 
EPDS,PRAQR2, 
SCL,RDAS at 
gwks 34 
  Questionnaires: 
RRIs, respiratory 
infections, 
antibiotic 
treatments 
Study 
II 
Maternal PD is 
related to early 
infant HPA 
axis reactivity 
in the context 
of subclinical 
rhinovirus 
infection 
Questionnaires 
EPDS, PRAQR2, 
SCL, RDAS at 
gwks 14,24 and 
34 (Focus cohort) 
 Saliva 
cortisol 
samples, 
NPS for 
virus 
PCR, e.g 
rhinovirus 
 
Study 
III 
To assess the 
impact of 
polymorphisms 
in type I 
interferon 
related gene 
IFI44L on 
susceptibility 
to RTIs and 
AOM 
- Cord 
blood 
mRNA 
blood 
samples, 
NPS for 
virus PCR 
Questionnaires: 
respiratory 
infections, 
antibiotic 
treatments 
Study 
IV 
The risk for 
RRIs is 
elevated in 
children with 
innate immune 
gene variants, 
and maternal 
PD might 
further 
increase the 
risk 
Questionnaires 
EPDS, PRAQR2, 
SCL, RDAS at 
gwks 34 
Cord 
blood 
 Questionnaires: 
RRIs, respiratory 
infections, 
antibiotic 
treatments 
The Edinburgh Postnatal Depression Scale (EPDS), Gestational week (GWK), Nasopharynx/nasal 
sample (NPS), Polymerase chain reaction (PCR), Prenatal psychological distress (PD), Pregnancy-
Related Anxiety QuestionnaireRevised2 (PRAQ-R2), Recurrent respiratory tract infection (RRI), the 
Revised Dyadic Adjustment Scale (RDAS) questionnaires and the Symptom Checklist 90 anxiety 
subscale (SCL90/Anxiety). 
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4.2 Study population 
Recruitment took place at three maternal welfare clinics of a geographically defined 
area, which performed pregnancy ultrasound scans at gwk 12 for the women 
eventually referred to give birth at the Turku University Hospital in the Hospital 
District of Southwest Finland and the Åland Islands in Finland.  The recruitment 
took place between December 2011 and April 2015 and relied upon personal contact 
by research nurses, who were placed at the recruitment sites. The cohort consisted 
of 3808 women, who attended the free-of-charge ultrasounds during early 
pregnancy, their 3837 babies and 2623 fathers or partners. Mothers and fathers were 
considered eligible to participate in the study if they had a verified pregnancy and 
sufficient knowledge of Finnish or Swedish (the official languages of Finland) to fill 
in the study questionnaires. 
The study population regarding children with RRIs (Study I) was selected from 
among the Cohort participants, who had responded to the 12- and 24- month 
questionnaires on child health by December 2017 (N=1262). Of the entire RRI 
group, 91 children were included based on the 12-month questionnaire (6% of cohort 
children) and the remaining 155 (11% of cohort children) based upon the 24-month 
questionnaire. There were 40 families (20%) out of the 204 who had responded “yes” 
to the question on RRIs both at 12 and 24 months. The group of children without 
RRIs were also selected on the basis of parental responses on the 12-month and 24-
month questionnaires. Responding “no” regarding recurrent infections at both time 
points was the criterion to be in the comparison group (N= 1014). Within these 
children, genotyping from cord blood was successful with 990 children. Thus, Study 
IV consisted of 96 children with RRIs and of a comparison group of 894 children. 
Within the main Cohort, a nested case-control study, called the Focus Cohort, 
was established to enable comparisons between subjects exposed to different types 
of prenatal psychological distress and their non-exposed controls. To define maternal 
psychological distress, the questionnaires for symptoms of depression (Edinburgh 
Postnatal Depression Scale [EPDS]), overall anxiety (Symptom Checklist-90, 
anxiety scale [SCL-90]) and pregnancy-related anxiety symptoms (Pregnancy-
Related Anxiety Questionnaire-Revised 2 [PRAQ-R2]) were used at gwks 14, 24, 
and 34. Exploratory analyses establishing cut-points for the approximately highest 
and lowest 25th percentiles of maternal psychological distress during pregnancy 
were performed. The total sum score cut-off points for the psychological distress 
exposure and non-exposure were as follows: ≥ 12 and  ≤ 6 for the EPDS,  ≥10 and  
≤ 4 for the SCL-90 anxiety subscale and ≥ 34 and ≤ 25 points for PRAQ-R, 
respectively (Karlsson et al., 2018). To become identified as a case required: 1) 
scoring at least once above the selected threshold on two different questionnaires, or 
2) scoring at least twice above the selected threshold on the same instrument at any 
of the three prenatal time points or 3) prenatal maternal use of serotonin reuptake 
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inhibitors (SSRIs) should have occurred. The non-exposed controls needed to remain 
below the thresholds in all assessments (Karlsson et al., 2018). 
Due to project logistics (i.e., availability of assisting personnel) and factors not 
systematically related to any family characteristics, 792 families from the Focus 
Cohort target population (N = 1219) were attempted to be reached by phone for 
recruiting the infants for Study II. Out of those families who were reached (N = 586), 
a total of 418 (71%) agreed to participate in the study, and 168 (21%) declined. 
Eventually 374 infants attended the stress test, and 38 infants were excluded from 
the data analyses. Eleven children were excluded from the cortisol analyses, as 4 
children had extremely high cortisol concentrations, and mothers of 7 children did 
not fulfill the criteria for the Focus Cohort. Six children were excluded from the nasal 
sample (NPS) virologic analyses, two because the mother denied the nasal sampling, 
there was no consent for the NPS regarding one child and 3 NPS were not 
successfully studied in the laboratory. 21 children were excluded from the AUC 
analyses due to less than 3 cortisol measurements Thus, the final analyses in Study 
II comprised 336 infants with adequate cortisol and virologic samples. 
Study III consisted of two cohorts being the Steps to the Healthy Development 
and Well-being of Children (STEPS) Study and the FinnBrain Birth Cohort. The 
STEPS Study is a cohort of 1135 children born between years 2008-2010 in the 
Hospital District of Southwest Finland. Blood samples for genetic analyses were 
obtained from STEPS study children at the age of two months. Children were 
followed intensively for respiratory infections from birth to two years of age 
(Toivonen et al., 2016b). In the FinnBrain Birth Cohort Study, a total of 1443 
children were followed for respiratory infections from birth to one year of age. At 
the age of 3 months children were examined by a study physician in the FinnBrain 
Birth Cohort Study, and nasal swabs were collected as well as bloods samples for 
mRNA analyses (N = 71). Cord blood was used for genotyping. The final analysis 
included children with successful genotyping and information on respiratory 
infections (N = 971 for rs273259 and N = 972 for rs133969) (Figure 2). 
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Figure 2.  Flow chart of study participants in Studies I, II, III and IV. Interferon-induced protein 44-
like (IFI44L), Nasopharynx/nasal sample (NPS), Steps to the Healthy Development and 
Well-being of Children (STEPS). 
4.3 Self-report questionnaires 
The parents answered the questionnaires at gwks 14, 24 and 34 as well as at child 
ages of 3, 6, 12, and 24 months. The data on background factors were collected from 
maternal questionnaires. Pregnancy and infant birth characteristics were obtained 
from the Finnish Medical Birth Register kept by the National Institute for Health and 
Welfare of Finland (www.thl.fi). In this work, the source of prenatal stress data were 
questionnaires of maternal symptoms of depression, anxiety and pregnancy specific 
anxiety (i.e., psychological distress). 
4.3.1 Psychological distress: symptoms of depression and 
anxiety and relationship satisfaction/quality 
Parental depressive symptoms were assessed using the Edinburgh Postnatal 
Depression Scale (EPDS). The EPDS is a widely used and sensitive meter of both 
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postnatal and prenatal depressive symptoms with 10 items each rated from 0 to 3 
(higher scores indicate more depressive symptoms)(Cox et al., 1987). Parental 
symptoms of anxiety were assessed using the Symptom Checklist 90 (SCL-90) 
anxiety subscale, which is a reliable and valid symptom measure consisting of 10 
items each rated from 0 to 5 (Derogatis et al., 1983). Again, higher scores indicate 
more pronounced symptoms.  
Pregnancy-specific anxiety was assessed using The Pregnancy-Related Anxiety 
Questionnaire–Revised (PRAQ-R2), a 10-item shortened version of the PRAQ. The 
items of the PRAQ-R2 can be ordered into three subscales (Huizink et al., 2016). 
The first subscale called, “Fear of giving birth,” consists of three items such as “I am 
worried about the pain of contractions and the pain during delivery.” The second 
subscale called, “Worries about bearing a physically or mentally handicapped child,” 
consists of four items, including “I sometimes think that our child will be in poor 
health or will be prone to illnesses.” The third subscale called, “Concern about own 
appearance,” consists of three items, such as “I am worried about my enormous 
weight gain.” Scores on each item ranged from 1 to 5.  
Relationship satisfaction was assessed using the Revised Dyadic Adjustment 
Scale (RDAS), a 14-item version of the DAS24, measuring couple/partner 
adjustment in three domains (Busby, D. M., Christensen, C., Crane, D. R., & Larson, 
1995). Factor 1 Consensus consists of items called, “Career decisions,” and 
“Religious matters” (with answers being always agree, almost always agree, 
occasionally agree, frequently disagree, almost always disagree and always 
disagree). Factor 2 being, “Satisfaction,” consists of items called, “How often do you 
discuss or have you considered divorce, separation, or terminating your 
relationship?” and “How often do you and your partner quarrel?” (with answers 
being all the time, most of the time, more often than not, occasionally, rarely and 
never). Factor 3 called, “Cohesion,” consists of items such as, “Work together on a 
project” and “Calmly discuss something” (with answers of: never, less than once a 
month, once or twice a month, once or twice a week, once a day and more often). 
Each item is scaled from 1 to 6, the total scores thus ranging from 14 to 84. Higher 
scores represent lower levels of relationship satisfaction.  
Continuous sum scores of the EPDS, SCL-90/anxiety PRAQ-R2 and RDAS 
subscale were used in Study I, as this general population-based sample was likely to 
yield a very low number of subjects scoring above the clinical thresholds. In Study 
IV, a cut point of 10 points in The Edinburgh Postnatal Depression Scale was used 
as a marker for clinical depression and the upper quartile of Pregnancy-Related 
Anxiety Questionnaire–Revised2 (≥ 26 points) was the indicator for high stress. 
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4.4 Respiratory virus PCR 
The nasal swab specimen for respiratory virus assessment was taken from front 
nostril and stored at -80°C before the analysis. Swabs were suspended in phosphate-
buffered saline, and nucleic acids were extracted by NucliSense easyMag 
(BioMerieux, Boxtel,the Netherlands) or MagnaPure 96 (Roche, Penzberg, 
Germany) automated extractor. Polymerase chain reaction (PCR) for adenovirus, 
bocavirus, coronaviruses, enteroviruses, metapneumovirus, influenza A and B 
viruses, respiratory syncytial virus A and B, rhinovirus and parainfluenza virus types 
1-4 was performed using a commercial multiplex test kit (Anyplex  RV16, Seegene, 
Soul, Korea) 
4.5 Genotyping of innate immunity genes and 
mRNA analyses 
In the FinnBrain study, DNA samples were extracted according to standard 
procedures at the National Institute for Health and Welfare. DNA samples were 
genotyped with Illumina Infinium PsychArray BeadChip comprising 603132 SNPs 
(single nucleotide polymorphism) at the Estonian Genome Centre, and quality 
control (QC) was performed with PLINK (Chang et al., 2015). Markers were 
removed for missingness (> 5%) and the Hardy-Weinberg equilibrium (P-value 
< 1x10-6). Individuals were checked for missing genotypes (> 5%), relatedness 
(identical by descent calculation, PI_HAT> 0.2) and population stratification 
(multidimensional scaling). In Study IV, genotyped data was inputted with 
IMPUTE2 using the 1000 Genomes project phase 3 haplotypes and a haplotype set 
of 1941 whole genome sequenced Finnish individuals as reference panels. 
Individuals were checked for missing genotypes (> 5%), relatedness (identical by 
descent calculation, PI_HAT> 0.2) and population stratification (multidimensional 
scaling). Genotyped data was inputted with IMPUTE2 using the 1000 Genomes 
project phase 3 haplotypes and a haplotype set of 1941 whole genome sequenced 
Finnish individuals as reference panels (Howie et al., 2009). 
In the STEPS Study, DNA samples were extracted according to standard 
procedures in Immunogenetics Laboratory, University of Turku. For genetic 
analysis, IFI44L single nucleotide polymorphisms rs273259 and rs1333969 were 
analysed using the Sequenom (San Diego, California, USA) platform (Genome 
Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland). 
For mRNA transcriptional profiles whole blood samples were collected during a 
pre-scheduled study visit at 3 months of age. 1 ml of blood was drawn in Tempus 
tubes (Applied Biosystems, Foster City, CA, USA) and stored at -20 °C. RNA was 
extracted and hybridized to Illumina HT-12 V4 beadchips (Illumina, San Diego, CA, 
USA).  After hybridization, beadchips were scanned on the Illumina Beadstation 500 
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and Illumina GenomeStudio software (Illumina, San Diego, CA, USA) was used to 
subtract background and for average signal intensity scaling (average 
normalization). All raw expression values <10 were set to 10 and the data was log2-
transformed. 
4.6 Outcomes 
Study I’s outcomes were recurrent respiratory infections at the child age of 12 and/or 
24 months. Children with RRIs were identified from maternal reports with a 
question: “Has your child had recurrent infections” (with an answer choice of 
yes/no). This single question was applied as a method to determine the RRI group, 
as no absolute consensus exists on the number of infections per year that would 
define recurrent infections. Information on the number and timing (i.e., the child’s 
age) of infections and antibiotic treatments as well as the number of physician visits 
at ages 3, 6, 12 and 24 months, and any physician-assessed pediatric diagnoses were 
inquired. The number of RTIs was then categorized in four groups: 0, 1-4, 5-10 and 
> 10, and the number of antibiotic treatments into groups: 0, 1-4, and 5-10 and > 10. 
The categorization was made because mothers had responded inaccurately to 
questionnaires on the number of infections or antibiotic treatments, for example, 3 
to 6 or “too many.” As the number of infections and antibiotic treatments had also 
been requested monthly before one year of age, the number of infections/antibiotic 
treatments was partially revised. 
Study II’s outcome was the infant’s HPA axis reactivity. The stressor included a 
standardized pediatric examination with a venipuncture and a nasal swab with each 
being a source of mild physical discomfort. The infant HPA axis reactivity to the 
stressor was assessed measuring five saliva cortisol samples: at baseline, 0, 15, 25 
and 35 minutes after a stressor. The saliva cortisol samples were collected using 
Salimetrics infant swabs (Stratech, Suffolk, UK) by a research nurse or a researcher. 
The polymer swab was held in an infant’s mouth for two minutes. Saliva was 
collected by centrifuging tubes (15 minutes, 1800 g, 4°C) and immediately frozen at 
-70°C. The research nurse filled the protocol record form to keep track of timing, 
infant feeding and possible deviations from the study protocol. The cortisol 
concentrations were measured with a Cortisol Saliva Luminescence Immunoassay 
(IBL International, Hamburg, Germany). 
Study III’s outcomes were the association of IFI44L-gene polymorphisms 
rs273259 and rs1333969 with the frequency of RTIs, the number of rhinovirus 
infections, number of episodes of AOM and number of days with respiratory disease 
symptoms during the first two years of age in the  Steps to the Healthy Development 
and Well-being of Children (STEPS) study. The findings were validated in the 
FinnBrain Birth Cohort study conducted geographically from the same area. In the 
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FinnBrain Birth Cohort study, the number of RTIs was then categorized in four 
groups: 0, 1-4, 5-10 and > 10, and the number of antibiotic treatments in the three 
groups with 0, 1-4 and 5 treatments or more. Each separate episode in a one-month 
period and any episode reported to continue over the turn of the month, were defined 
as a separate event. The effect of these gene polymorphisms on blood messenger 
RNA (mRNA) transcriptional profiles were analyzed in a subset of study subjects in 
the FinnBrain study. 
Study IV’s first outcome was the association of preselected genetic variants 
affecting the function of innate immune system ( IL6, IFI44L, IL10, IFIH1, MBL2, 
IL17A, TLR4, TLR2, IL4 and TNF ) with the clinical outcome of recurrent respiratory 
infections after adjusting for sex. A second outcome was to analyze children with 
genetic variants of innate immunity and in utero exposure of maternal psychological 
distress for a higher risk score regarding RRIs defined as the interactions among the  
IL-6 Rs1800795 polymorphism and the IFI44L gene rs273259 and rs1333969 
polymorphisms and the maternal prenatal symptoms of depression and pregnancy 
specific anxiety. 
4.7 Covariates and potential confounders 
In Studies III and IV, genetic analyses were adjusted for sex. In Studies II and IV, 
analyses were also done separately for girls and boys. Maternal age at the birth of 
child (Study I, II and IV) and number of siblings (Study I and III) were included as 
potential confounders. Maternal educational level was included in Study I, II and IV. 
Maternal educational level was categorized into low (up to 12 years of education), 
medium (13-15 years of education) and high (over 15 years of education). Study I’s 
covariates included gestational age (weeks), maternal smoking during the postnatal 
period (with an answer of yes/no), duration of breastfeeding (months), daycare 
attendance at the child age of 12 months (with an answer of yes/no) and the number 
of daycare days per week. Study II’s covariates included: gestational age (weeks), 
birth weight (g) / length (cm), head circumference (cm), umbilical artery blood pH, 
maternal pre-pregnancy body-mass index (kg/m2), maternal use of inhaled or oral 
corticosteroids (with an answer of yes/no), maternal smoking during the postnatal 
period (with an answer of yes/no) and maternal use of SSRIs (with an answer of 
yes/no). Study IV’s covariates included: maternal smoking during the postnatal 
period (with an answer of yes/no), gestational age (weeks) and an Apgar score at 1 
minute of age. 
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4.8 Statistical analyses 
Study I 
All statistical analyses were conducted using IBM SPSS v.24.0 (SPSS Inc, Chicago, 
IL, USA). Sociodemographic and other background data as well as questionnaire 
data were compared between the RRI group and comparison group by using a χ² or 
a Mann-Whitney U test.  
Binary logistic regression was used to study the association between maternal 
prenatal psychological distress and a child’s RRI status. The dependent variable was 
RRIs (0 = no, 1 = yes), and independent variables were duration of gestation, 
duration of breastfeeding, number of siblings, maternal smoking at the child age of 
3 months (yes/no), maternal level of education, maternal depressive (EPDS) and 
anxiety (SCL-90/anxiety) symptoms at the child age of 2 years. These covariates 
were included, as they are previously identified and are well-established risk factors 
for RRIs. Postnatal symptoms of depression or anxiety were included to control for 
possible maternal report bias. As all the children were not born full-term, gestational 
age was also included as a potential covariate in the analyses. Due to 
multicollinearity, separate analyses were performed for each questionnaire (EPDS, 
SCL-90/anxiety, PRAQ-R2 and RDAS total sum scores). Analyses with prenatal 
EPDS and RDAS total sum scores were adjusted by maternal EPDS score at the child 
age of 2 years, and the analyses with prenatal SCL-90/anxiety and PRAQ-R2 scores 
were adjusted by maternal SCL-90/anxiety score at the child’s age of 2 years. The 
effect of a rise on the EPDS score on the RRI risk as an OR was calculated by using 
a 3-point rise, i.e., minimum versus maximum points per question (max. sum = 30 
points), SCL score OR by using a 5-point rise (max. sum = 50), PRAQ-R2 total sum 
score OR by using a 5-point rise (max. sum = 50) and RDAS total sum score OR 
was estimated by using a 6-point rise (max. sum = 84). 
Study II 
As the measure for the HPA axis reactivity, the area under the curve above/below 
the baseline (AUCi) was used (Figure 3). Log-transformed (natural logarithm) 
cortisol values were used in the calculations to avoid severe outlying AUCi values. 
Only the infants with a baseline cortisol value and ≥ 2 measured/available cortisol 
values after the acute stressor were included in the analyses. 
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Figure 3.  Illustration of AUCi:  Area under the curve above/below baseline with respect to baseline 
(AUCi). 
The missing cortisol values for the infants included in the analyses were inputted 
using multiple inputation. The predictive mean matching multiple inputation 
technique, by constructing 50 complete datasets, was used to input the missing 
cortisol values such that all included subjects had all four of the cortisol value 
measuring timepoints of 0, 15, 25 and 35 minutes cortisol values (Little, 1988). The 
missing values were predicted using the other cortisol values, their measurement 
time points, after the acute stressor, and the cortisol measurement kit as the 
predictors, with one kit/antibody for each sample was used to analyze the cortisol 
samples. After input, the area under the cortisol curve, between 0 and 35 minutes, 
above/below baseline (AUCi), was calculated for each subject, separately in each 50 
completed datasets. To be more precise, AUCi was defined as:  
𝐴𝐴𝐴𝐴𝐴𝐴𝑖𝑖 = � [𝑓𝑓𝑃𝑃𝑃𝑃(𝑡𝑡) − 𝑐𝑐𝑐𝑐𝑐𝑐𝑡𝑡𝐵𝐵𝐵𝐵]𝑑𝑑𝑡𝑡35
0
 
where fPW(t) is the piecewise linear approximation of the cortisol curve and cortBL 
is the baseline cortisol value (Figure 3). Finally, standard linear regression 
techniques were used to analyze the differences in AUCi. To test our main 
hypothesis, the model, AUC = psychological distress exposure + rhinovirus + 
psychological distress exposure × rhinovirus + sex, was used with such coding for 
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psychological distress exposure and rhinovirus that we were able to test the null 
hypothesis H0: µ psychological distress + = (µ psychological distress - + µcontrol+ 
+ µcontrol-) / 3 where µxx is the mean AUCi in group xx. The analyses were first 
made separately for each inputed dataset. The final results were then obtained by 
pooling the results using the Rubin’s rules (Rubin, 1987). The R package “mice” was 
used for multiple inputation (Stef van Buuren, 2011) and the package ggplot2 for the 
results shown in Figures 4 and 5 (Wickham, 2009). The analyses of how AUCi 
associated with the psychological distress exposure, being psychological distress vs. 
control, rhinovirus status (+ vs. -) and infant sex were done using the t-tests. The 
main hypothesis being that the HPA axis reactivity is altered in the psychological 
distress /rhinovirus+ group was tested with an appropriate linear regression model, 
where infant sex was also controlled. Covariates for the adjusted model were selected 
based on statistical and clinical relevance. All statistical analyses were performed in 
R v.3.5.1 (R Core Team 2018). 
Study III 
In the STEPS Study, the association between the heterozygous or homozygous 
IFI44L polymorphisms rs273259 and rs1333969 and the incidence rate of RTIs, 
rhinovirus infections, days with RTI symptoms, AOM episodes and antibiotic 
treatments for RTIs during the ages of 0-2 years were analyzed using negative 
binomial regression analysis with a natural logarithm of the follow-up time as an 
offset adjusting for sex and the presence of sibling(s) at birth (using R version 
v.3.5.3). In the FinnBrain Birth Cohort Study, the association between the 
polymorphisms rs273259 and rs1333969 and RTIs and also antibiotic treatments 
were first tested with linear regression analysis implemented with PLINK (Purcell). 
The number of RTIs from birth to 1 year of age were then categorized into four 
groups 0, 1-4, 5-10, and > 10 infections. The number of antibiotic treatments from 
birth to 1 year of age were categorized into three groups being those with 0, 1-4, and 
5 or more antibiotic treatments. The final analysis with adjustment for sex and the 
presence of sibling(s) at birth was done using ordinal logistic regression to explore 
whether the odds of being in a higher category was associated with the heterozygous 
or homozygous polymorphisms of IFI44L. Regression analyses were performed 
using R v.3.5.3 with the polar function in the MASS package.  
For IFI44L expression, HT-12 V4 beadchips contained two probes targeting 
IFI44L (ILMN_1723912 and ILMN_1835092). The expression values of these two 
probes were highly correlated (Spearman r = 0.906, P < 0.0001) and the mean of the 
two probes was used as expression value for IFI44L. Expression values were 
analyzed according to genotype and virus detection and compared by a Mann-
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Whitney test. Analysis was performed using GraphPad Prism software v. 8.0.0 
Graphpad, San Diego, CA, USA.  
Study IV 
Sociodemographic, other background and questionnaire data were compared 
between the RRI and the comparison group by using a t-test, χ² or Mann-Whitney U 
test where appropriate. The association between preselected genetic variants of the 
innate immune system and RRIs was tested with the logistic regression analysis 
implemented with PLINK (Purcell) and adjusted for sex. The alleles were classified 
according to allele frequency so that the associations depended additively on the 
minor allele (Additive model), which is children having two minor alleles where 
labelled as (2), for having a minor/major genotype as (1) and a major/major genotype 
as (0).  
Interactions between genotype and maternal prenatal psychological distress were 
analyzed using logistic regression models of the form:  
RRI = Distress + Genotype + Distress × Genotype 
where “RRI” was a binary variable (0 = No, 1 = Yes), “Distress” was either 
categorized EPDS (< 10 points = Low, High ≥ 10 points) or categorized PRAQ-R2 
(< 26 points = Low, High  ≥ 26 points ) and “Genotype” was a continuous variable 
labeled as above. The additive models were used to analyze the associations between 
genotype and RRIs separately in the children with or without in utero exposure of 
maternal psychological distress. EPDS and PRAQ-R2 were selected based on 
statistical relevance as group comparison between the RRI-group and the 
comparison group showed significant difference in the EPDS and PRAQ-R2 
questionnaire total scores at gwks 34. All statistical analyses were conducted using 
IBM SPSS v.24.0 (SPSS Inc, Chicago, IL, USA) and R v.3.6.1. (R Core Team, 
2019). 
4.9 Ethics 
The STEPS Study and the Finnbrain Study protocols were approved by the Ethics 
Committee of the Hospital District of Southwest Finland. The parents of the 
participating children gave written informed consent on their own and on their 
child’s behalf. The participants were informed that they could discontinue at any 
time without having to give an explanation. The Finnish legal regulation protocols 
were followed in this study including collection and storage of biological samples. 
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5 Results 
5.1 Study population 
The FinnBrain Birth Cohort Study consisted of 3837 children (including 29 twin 
pairs) and their parents. Of these families, 310 discontinued the study by delivery 
and 57 by three months postpartum, including 24 miscarriages, 8 stillbirths and 3 
neonatal deaths. Pregnancy and infant birth characteristics from the Finnish Medical 
Birth Register were kept by the National Institute for Health and Welfare and were 
available for 3667 families (96.3%)(Karlsson et al., 2018). During the pregnancy of 
the 3808 mothers, 3095 (81.3%) answered the questionnaires at gwk 14, 2784 
(73.1%) at gwk 24 and 2609 (68.5%) at gwk 34. When the child was one year old, 
1693 (44%) mothers responded to the 12-month questionnaires, and when the child 
was two years old, 1443 (38%) mothers responded to the 24- month questionnaires. 
The FinnBrain Birth Cohort Study population resembles the general population 
with the possible exceptions of a lower prevalence of younger, multiparous and 
smoking mothers. Also the prevalence of preterm births was lower in the cohort than 
among all the deliveries at the Turku University Hospital (Karlsson et al., 2018). 
Karlsson et al. noted that mothers, who responded also to the gwk 34 questionnaires, 
were older, were more often primiparous, had higher socioeconomic status, smoked 
less frequently and reported lower depressive symptom scores at gwk 14 than those 
who did not return the third trimester questionnaires (Karlsson et al., 2018). Children 
in the STEPS Study were also more often first-borns and were from families with a 
higher maternal educational level (Lagström et al., 2013). 
In Study I and IV, with a partially overlapping population, there were no 
differences between the RRI-group and comparison group regarding mother’s age 
and smoking during the postnatal period. In Study I, not all children in the population 
were born full-term, and this resulted in a significant difference between the RRI-
group and comparison group. The duration of breastfeeding was shorter in the RRI-
group, and there were more often siblings in the family. In Study II, there were no 
differences regarding infant characteristics at birth between the prenatal 
psychological stress-exposed children and their controls. Maternal educational level 
was significantly lower in the prenatal psychological stress -exposed group as well 
as maternal smoking during pregnancy was more common.  
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Table 3.  Study populations. 
 Population (N) Excluded (N) Study population (N) 
Study I 1262 families responded 
12- and 24-month 
questionnaires 
44 (lack of data) 1218 
Study II 374 families attended 
the stress test  
38 (lack of data) 336 
Study III 1693 families responded 
12-month questionnaires 
721 (No information of 
genotype) 
971 IFI44L(rs273259)  
972 IFI44L(rs133969) 
Study IV 1262 families responded 
12- and 24-month 
questionnaires 
272 (No information of 
genotype) 
990 
5.2 Prenatal maternal psychological distress and 
risk for RRIs. (Study I) 
In Study I, children were followed from birth to two years of age. Of the entire RRI 
group, 91 children were included based on the 12-month questionnaire (6% of cohort 
children) and the remaining 155 (11% of cohort children) were based on the 24-
month questionnaire. There were 40 families (20%) out of the 204 who had 
responded “yes” to the question on RRIs both at 12 and 24 months. By one year of 
age, 30% of children in the RRI-group had five or greater number of RTIs, while 
only 5% of children in the comparison group had five or greater number of RTIs. 
Corresponding percentages for more than five antibiotic treatments were 20% versus 
0.06% at one year of age. The majority (77%) of children in the RRI group had more 
than five respiratory infections before two years of age, while 16% of the comparison 
group reported more than five RTIs. 57% of children in the RRI-group had more 
than five antibiotic treatments, while 5% of children in comparison group had 5-10 
antibiotic treatments. Half of the children in the RRI group had tympanostomy tubes 
inserted, whereas in the comparison group, only 4% of the children had tubes 
inserted.  
Group comparisons showed significant differences in all maternal prenatal 
psychological distress questionnaires, as RRI group mothers reported significantly 
higher scores on EPDS-, PRAQ-R2-, SCL-90/anxiety- and RDAS-questionnaires. 
Mothers of the RRI-group had elevated levels of symptoms of depression (P < 
0.001), pregnancy-specific anxiety (P = 0.001), anxiety (P = 0.04) and lower levels 
of parental relationship satisfaction (P = 0.008) when compared with the comparison 
group (Table 4). Postnatally, the RRI group mothers reported more symptoms of 
depression, anxiety and lower levels of relationship satisfaction, when the child was 
two years old (P = 0.001, P = 0.03, P = 0.003, respectively) (Table 4). 
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Table 4.  Mean (SD) values of total scores of the Pregnancy-Related Anxiety Questionnaire–
Revised2 (PRAQ-R2), the Symptom Checklist 90 anxiety subscale (SCL90/Anxiety), the 
Edinburgh Postnatal Depression Scale (EPDS) and the Revised Dyadic Adjustment 
Scale (RDAS) questionnaires in recurrent respiratory tract infections (RRI) and 
comparison groups.  
  Mothers 
  RRI-group1 Comparison group2 P value 
PRAQ-R2 gwks 34 24.2(6.9) 22.6 (6.5) 0.001 
SCL90/Anxiety gwks 34 3.8 (4.5) 3.0 (3.8) 0.04 
 child 24 mo 3.5 (4.3) 2.5 (3.8) 0.03 
EPDS gwks 34 5.6 (4.2) 4.4 (4.0) <0.001 
 child 24 mo 5.4 (4.1) 4.3 (4.1) 0.001 
RDAS gwks 34 32.1 (8.0) 30.4 (6.0) 0.008 
 child 24 mo 34.0 (8.6) 31.7 (7.4) 0.003 
Data available N at gestational weeks (gwks) 34 /at child 24 months (mo): 1) PRAQ 188/-, SCL 
191/177, EPDS 192/177, RDAS 189/169; 2) PRAQ 983/-, SCL/Anxiety 982/1006, EPDS 986/1006, 
RDAS 967/967. P values are based on Mann-Whitney U tests. 
Logistic regression analyses were performed to see if the associations between 
maternal prenatal psychological distress and the child’s RRIs remained after 
adjusting for the selected covariates. Analyses with prenatal EPDS and RDAS total 
sum scores resulted in an OR of 1.24 (95% CI 1.08-1.44) and an OR of 1.32 (95% 
CI 1.01-1.58), respectively, for a child´s RRIs. Regarding the prenatal maternal 
anxiety symptom questionnaires, ORs for a child’s RRIs were 1.40 (95% CI 1.01-
1.76, SCL/90 anxiety scale) and 1.28 (95% CI 1.11-1.47, PRAQ-R2). To conclude, 
when taking into account the number of siblings and the duration of breastfeeding 
and post-natal symptoms of depression and anxiety, psychological stress during the 
pre-natal period remained an independent RRI risk factor in our analyzes of the first 
24 months of postnatal life (Table 5). 
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Table 5.  Results of binary logistic regression analyses on maternal psychological distress at 
gestational weeks 34 predicting child recurrent respiratory tract infections (RRIs) by the 
age of two years (N = 1218) separately for each questionnaire (EPDS, SCL90/Anxiety, 
PRAQ-R2, RDAS).  
MODEL 1 OR 95% CI P value 
EPDS at gwks 34 
The duration of breastfeeding 
1.24 
0.90 
1.08–1.44 
0.82–0.98 
0.003 
0.02 
N siblings 1.32 1.08–1.62 0.008 
The duration of gestation 0.96 0.86–.08 0.53 
Maternal level of education (ref. High)   0.06 
Low  0.73 0.45–1.20 0.21 
Middle  1.34 0.89–2.05 0.17 
Maternal smoking 1.15 0.57–2.34 0.70 
EPDS at the child age of 2 years 1.01 0.97–1.06 0.60 
MODEL 2    
SCL90/Anxiety at gwks 34 
The duration of breastfeeding 
1.40 
0.9 
1.01–1.76 
0.83–0.99 
0.006 
0.02 
N siblings 1.36 1.11–1.67 0.003 
The duration of gestation 0.95 0.85–1.07 0.42 
Maternal level of education (ref. High)   0.045 
Low  0.74 0.45–1.20 0.22 
Middle  1.38 0.90–2.11 0.14 
Maternal smoking 1.2 0.60–1.66 0.60 
SCL90/Anxiety at the child age of 2 years 1.00 0.96–1.1 0.74 
MODEL 3    
PRAQ-R2 at gwks 34 
The duration of breastfeeding 
1.28 
0.90 
1.11–1.47 
0.83–1.00 
0.001 
0.02 
N siblings 1.46 1.18–1.80 <0.001 
The duration of gestation 0.9 0.83–0.99 0.58 
Maternal level of education (ref. High)   0.048 
Low  0.73 0.45–1.20 0.21 
Middle  1.37 0.89–2.10 0.15 
Maternal smoking 1.14 0.55–2.38 0.72 
SCL90/Anxiety at the child age of 2 years 1.02 0.98–1.08 0.38 
MODEL 4    
RDAS at gwks 34 
The duration of breastfeeding 
1.32 
0.90 
1.01–1.58 
0.82–0.98 
0.003 
0.02 
N siblings 1.32 1.08–1.62 0.007 
The duration of gestation 0.95 0.85–1.07 0.42 
Maternal level of education (ref. High)   0.07 
Low  0.75 0.46–1.23 0.25 
Middle  1.35 0.88–2.08 0.17 
Maternal smoking 1.14 0.56–2.32 0.72 
EPDS at the child age of 2 years 1.04 1.00–1.08 0.08 
Independent variables: EPDS, SCL90/Anxiety, PRAQ-R2 total sum, RDAS total sum, at gestational 
weeks 34, duration of breastfeeding, number of siblings, duration of gestation, maternal smoking 
and level of education. Mothers’ EPDS or SCL90/Anxiety score at the child age of 2 years. RDAS: 
The Revised Dyadic Adjustment Scale; EPDS: The Edinburgh Postnatal Depression; 
SCL90/Anxiety: Symptom Checklist 90 (SCL-90)/anxiety subscale; The Pregnancy-Related Anxiety 
Questionnaire–Revised (PRAQ-R2) 
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5.3 Prenatal maternal distress associates with 
blunted HPA axis function in rhinovirus-positive 
infants. (Study II) 
Within the FinnBrain Birth Cohort, a nested case-control study, the Focus Cohort, 
was established to enable comparisons between subjects exposed to different types 
of prenatal psychological distress with their non-exposed controls (see: Methods 
section, pages 30-31). Study II includes a subset of children from Focus Cohort, that 
is, 336 10-week-old infants who participated in study visits and stress tests. Of these 
infants, 177 (53%) were boys, 148 (44%) were exposed to psychological distress and 
76 (23%) were rhinovirus-positive (Table 6). Virus positive children did not have 
any signs of acute infection during study visit. Other viruses than the rhinovirus 
presented with only single positive findings in this general population-based study 
population.  
Table 6.  Study characteristics. P values are based on χ² and Mann-Whitney U tests for 
categorical and continuous variables, respectively. Bold values signify significance. PD: 
prenatal psychological stress; SD: standard deviation. 
 
PD EXPOSED 
(N = 148) 
CONTROLS 
(N = 188) 
 
P VALUE 
Infant characteristics at birth    
Gestational age, weeks (SD) 39.4 (1.4) 40.0 (1.6) 0.30 
Birth weight, g (SD) / length, cm (SD) 3595 (440)/ 51 (2) 3581 (487) / 51 (2) 0.69/0.89 
Head circumference, cm (SD) 35 (1.3) 35 (1.5) 0.90 
Umbilical artery, pH (SD) 7.27(0.8) 7.28 (0.8) 0.13 
Male sex, nr (%) 80 (54) 97 (52) 0.65 
Maternal characteristics during pregnancy    
Maternal age at birth, years (SD) 30 (4.5) 31 (4.3) 0.05 
Maternal pre-pregnancy body-mass index,kg/m2 (SD) 25.1 (5.1) 24 (4.0) 0.11 
Maternal education, nr (%) 
low (up to 12 years) 
middle (13-15 years) 
high (over 15 years) 
 
63 (44) 
36 (24) 
47 (32) 
 
48 (25) 
56 (30) 
84 (45) 
0.004 
Maternal smoking, nr (%) 24 (16) 6 (3) <0.001 
Maternal use of inhaled or oral corticosteroids, nr (%) 3 (2) 7 (4) 0.37 
Rhinovirus-positive infants at stress test, nr (%) 31(21) 45 (24) 0.50 
Infant age at stress test, weeks (SD) 10.8 (2.0) 10.6 (2.0) 0.21 
 
The infant HPA axis reactivity to the stressor was assessed measuring five saliva 
cortisol samples: baseline, 0, 15, 25 and 35 minutes after a stressor. The stressor 
included during study visit a standardized pediatric examination and blood sampling 
along with a nasal swab collection in the laboratory during the study visits. The infant 
HPA axis reactivity was not independently associated with the prenatal 
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psychological distressexposure (P = 0.30) or rhinovirus status (P = 0.09), but girls 
had higher AUCi than boys (P = 0.003) (Figure 4).  
 
Figure 4. During the stress test, AUCi was compared between: a) PD and control, b) rhinovirus- 
and rhinovirus+ or between c) girls and boys. The standard boxplots demonstrate the 
AUCi in the groups. AUCi: area under the curve above/below baseline; PD: exposure to 
prenatal psychological distress. 
The hypothesis that HPA axis activity is different in psychological distress/ 
rhinovirus + recombinant phenotype was tested by comparing psychological distress 
/rhinovirus+ group with the average of AUCi control/rhinovirus+, psychological 
distress /rhinovirus- and control/rhinovirus- groups, while controlling for infant sex. 
The subclinical rhinovirus constituted a natural stressor. The AUCi was lower in 
psychological distress /rhinovirus+ than in the other groups (difference: 14.7 ln 
[nmol/L] × min; 95% (CI) 3.8-25.6; P = 0.008) (Fig. 5). The same comparison was 
separately tested for boys and girls, and the AUCi difference was significant in boys 
(P = 0.04) but not in girls (P = 0.09) (Figure 5).  
Controlling for maternal education level and smoking did not affect the results 
(15.3 ln [nmol/L]×min; 95%CI 4.1-26.4; P = 0.007). Finally, we tested the role of 
the rhinovirus status within the prenatal psychological distress exposure group. The 
AUCi was lower in psychological distress /rhinovirus+ than in psychological distress 
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/rhinovirus- group (difference: 14.9 ln [nmol/L] × min; 95%CI 3.3-27.3; P = 0.01). 
Sensitivity analyses excluding the mothers using SSRIs or corticosteroids were 
performed to estimate the potential confounding effect of maternal medication. As 
the exclusion of these two groups did not alter the results, they were retained in the 
final analyses to maintain normal population representativity. 
 
Figure 5.  During the stress test: a) AUCi was compared between the PD/rhinovirus+ group and 
the average of control/rhinovirus+, PD/rhinovirus-, and control/rhinovirus- groups; b) 
mean cortisol values at five time points: baseline, 0 min, 15 min, 25 min and 35 min after 
stressor; and c) AUCi was compared between the groups separately in girls and boys. 
The standard boxplots demonstrate the AUCi in the groups. AUCi: area under the curve 
above/below baseline; PD: exposure to prenatal psychological distress. 
5.4 The relationship of IFI44L gene polymorphisms 
rs1333969 and rs273259 to respiratory 
infections. (Study III) 
In the STEPS Study, the final analysis included 1135 children that had genotypes 
and RTIs data including 738 with data on the rhinovirus etiology of RTIs. In the 
FinnBrain cohort, the final analysis included children with successful genotyping 
and data on RTIs (N = 970 for rs273259 and N = 971 for rs133969). Background 
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characteristics and allelic distribution of IFI44L polymorphisms in both cohorts are 
presented in Table 7 and RTI-related outcomes in Table 8 and 9. 
Table 7.  Background characteristics and allelic distribution of IFI44L polymorphisms in children 
in the STEPS Study and in the FinnBrain Birth Cohort Study. 
 STEPS Study, No. (%) 
(N = 1135) 
FinnBrain Cohort, No. (%) 
(N = 971) 
Female 612 (53.9) 464 (47.8) 
Older siblings 612 (53.9) 463 (49.3)a 
IFI44L rs273259   
    GG 147 (13.0) 133 (14.0)b 
    AG 497 (43.8) 441 (45.0) 
    AA 491 (43.3) 396 (41.0) 
IFI44L rs1333969   
    TT 80 (7.0) 79 (8.0) 
    CT 414 (36.5) 357 (37.0) 
    CC 641 (56.6) 535 (55.0) 
a Data is missing for 31 children. 
b N = 970 
5.4.1 IFI44L gene polymorphisms and respiratory tract 
infections in the STEPS Study cohort 
In the STEPS cohort, slightly decreased rates of days with RTI symptoms were 
observed for children with a CT (major/minor) genotype of rs1333969 compared to 
those with CC (major/major) genotype. The minor G allele of the rs273259 
polymorphism was associated with a decreased rate of AOM episodes (Table 7). 
Children with a homozygous GG (minor/minor) genotype had a lower rate of AOM 
episodes compared to children with the AA (major/major) genotype. Similarly, the 
minor T allele of the rs1333969 polymorphism was associated with a decreased rate 
of AOM episodes. The GG (minor/minor) genotype of the rs273259 and the TT 
(minor/minor) genotype of the rs1333969 were associated with lower rates of 
antibiotic treatments for RTIs compared to children with the respective major/major 
genotypes (Table 8).  
Results 
 49 
Table 8.  Association between IFI44L polymorphisms and rates of respiratory tract infections 
(RTIs) and related outcomes during the age of 0–2 years in the STEPS Study children 
(N = 1135). 
  
IFI44L gene 
polymorphism 
 
Genotype 
(No.) 
Incidence rate 
per child-year 
(95% CI)a 
 
Incidence rate 
ratio (95% CI)a 
 
P 
value 
RTIsa rs273259 AA (491) 6.0 (5.7–6.3) reference  
  AG (497) 5.8 (5.6–6.1) 0.98 (0.92–1.04) 0.46 
  GG (147) 5.7 (5.3–6.2) 0.97 (0.89–1.06) 0.56 
 rs1333969 CC (641) 6.0 (5.7–6.2) reference  
  CT (414) 5.7 (5.4–6.0) 0.96 (0.90–1.01) 0.14 
  TT (80) 6.0 (5.4–6.7) 1.04 (0.93–1.16) 0.46 
Rhinovirus-positive 
RTIsa 
rs273259 AA (319) 2.1 (1.9–2.2) reference  
  AG (321) 1.9 (1.7–2.0) 0.92 (0.83–1.03) 0.16 
  GG (96) 2.1 (1.8–2.5) 1.05 (0.89–1.24) 0.54 
 rs1333969 CC (409) 2.0 (1.9–2.2) reference  
  CT (269) 1.9 (1.8–2.1) 0.95 (0.85–1.06) 0.35 
  TT (58) 2.2 (1.8–2.6) 1.12 (0.93–1.36) 0.24 
Days with RTI 
symptomsa 
rs273259 AA (445) 52.2 (48.7–55.9) reference  
  AG (457) 50.0 (46.8–53.6) 0.96 (0.87–1.06) 0.41 
  GG (134) 45.6 (40.3–51.8) 0.90 (0.78–1.04) 0.13 
 rs1333969 CC (579) 52.7 (49.6–56.0) reference  
  CT (384) 47.2 (43.9–50.9) 0.89 (0.81–0.98) 0.02 
  TT (73) 48.8 (41.3–58.1) 0.96 (0.81–1.15) 0.67 
Acute otitis media 
episodesa 
rs273259 AA (491) 1.1 (1.0–1.2) reference  
  AG (497) 0.9 (0.8–1.0) 0.87 (0.75–1.01) 0.07 
  GG (147) 0.8 (0.6–1.0) 0.77 (0.61–0.96) 0.02 
 rs1333969 CC (641) 1.0 (1.0–1.2) reference  
  CT (414) 0.9 (0.8–1.0) 0.87 (0.75–1.01) 0.06 
  TT (80) 0.7 (0.6–1.0) 0.74 (0.55–0.99) 0.04 
Antibiotic 
treatments for RTIsa 
rs273259 AA (491) 1.4 (1.3–1.6) reference  
  AG (497) 1.3 (1.1–1.4) 0.89 (0.78–1.03) 0.13 
  GG (147) 1.0 (0.9–1.3) 0.76 (0.62–0.95) 0.02 
 rs1333969 CC (641) 1.4 (1.3–1.5) reference  
  CT (414) 1.3 (1.1–1.4) 0.91 (0.79–1.05) 0.18 
  TT (80) 1.0 (0.7–1.3) 0.73 (0.56–0.97) 0.03 
CI, Confidence Interval; RTI, Respiratory Tract Infection.  
a Incidence rates were analyzed using negative binomial regression analysis with natural logarithm 
of the follow-up time as an offset, adjusting for gender and the presence of sibling(s) at birth. 
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5.4.2 IFI44L gene polymorphisms and respiratory tract 
infections in the FinnBrain Study cohort 
In ordinal logistic regression analyses adjusted for sex and presence of sibling(s), the 
G allele of the rs273259 polymorphism in the IFI44L gene was associated with a 
lower number of RTIs during the first year of life in the FinnBrain Study Cohort. 
Children with the minor/minor genotype GG had an OR of 0.64 (95% CI, 0.42-0.97; 
P = 0.04), and children with the major/minor AG genotype an OR of 0.65 (95% CI, 
0.48-0.86; P = 0.003) for RTI frequency when compared to the major/major 
genotype (Table 9). The rs1333969 minor allele T was similarly associated with a 
decreased RTI frequency (Table 9).  
The heterozygous genotypes rs273259 AG and rs1333969 CT were significantly 
associated with decreased rates of antibiotic treatments for RTIs from birth to 1 year of 
age compared to the major/major genotypes (P = 0.02 and P = 0.04, respectively). The 
rates of antibiotic treatments were also lower in children with minor/minor compared to 
major/major genotypes of these polymorphisms, but the differences were not statistically 
significant. SNPs rs273259 and rs1333969 show mild linkage disequilibrium (r2=0.58) 
among the Finnish population (1000 Genomes Project Consortium et al., 2015).  
Table 9.  Associations between IFI44L polymorphisms and the frequency of respiratory tract 
infections (RTIs) and antibiotic treatments for respiratory infections in the FinnBrain 
cohort (N = 971 for rs133969 and N = 970 for rs273259). 
 IFI44L GENE 
POLYMORPHISM 
 
GENOTYPE (NO.) 
 
OR (95% CI)B 
P 
value 
RTISA IFI44L rs273259 AA (396) reference  
  AG (441) 0.65 (0.48–0.86) 0.003 
  GG (133) 0.64 (0.42–0.97) 0.04 
 IFI44L rs1333969 CC (535) reference  
  CT (357) 0.70 (0.53–0.94) 0.02 
  TT (79) 0.67 (0.40–1.09) 0.11 
Antibiotic treatments 
for RTIsc 
IFI44L rs273259 AA (396) reference  
  AG (441) 0.68 (0.50–0.93) 0.02 
  GG (133) 0.76 (0.48–1.18) 0.23 
 IFI44L rs1333969 CC (535) reference  
  CT (357) 0.72 (0.52–0.98) 0.04 
  TT (79) 0.92 (0.53–1.53) 0.75 
CI, Confidence Interval; OR, Odds Ratio; RTI, Respiratory Tract Infection. 
aThe frequency of acute respiratory infections from birth to 1 year of age was categorized in four 
groups: 0, 1-4, 5-10, and >10 respiratory tract infections. 
bOrdinal logistic regression adjusted for gender and presence of sibling(s) at birth. 
cAntibiotic treatments from birth to 1 year of age were categorized in three groups: 0, 1-4, and 5 or 
more antibiotic treatments. 
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5.4.3 Effects of IFI44L gene variants on peripheral blood 
transcription patterns 
Blood mRNA transcriptional profiles were analyzed in 71 children. These children 
had participated the FinnBrain birth cohort study visit at the age of 10 weeks and 
provided blood samples for mRNA analyses and NPS for respiratory tract virus 
detection. At least one respiratory virus, with rhinovirus being the most frequent, 
was detected in 25 (35%) of the children.  
First, we compared IFI44L expression in all children according to rs273259 and 
rs1333969 genotypes and found no differences (Figure 6, Panels A and B). Next, we 
compared the IFI44L expression in a subset of children (N = 25), who were positive for 
at least one respiratory virus. In these virus-positive children, the rs1333969 genotype 
CC (major/major) was associated with higher IFI44L expression (P = 0.0036). A similar 
finding was observed with rs273259 (P = 0.048) (Figure 6, Panels C and D). 
 
Figure 6.  Expression values of IFI44L according to IFI44L polymorphisms and virus detections. In 
all 71 children with transcriptome data available, there were no differences in the IFI44L 
expression according to rs1333969 (Panel A) or rs273259 (Panel B) genotypes. 
However, in a subgroup of children with respiratory virus detection at the time of mRNA 
sampling, IFI44L expression level differed according to genotype (Panels C and D). In 
virus-positive children, the rs1333969 major/major genotype was associated with higher 
IFI44L expression levels compared to other genotypes (major/minor and minor/minor 
genotypes combined) (Panel C; Mann-Whitney P =0.0036). A similar finding was 
observed with rs273259 (Panel D; P = 0.048). 
A) B) 
C) D) 
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To explore if different IFI44L genotypes were associated with differences in the 
expression of other genes, we first performed differentially expressed genes (DEGs) 
analysis among all children. No DEGs were detected when comparing rs273259 and 
rs1333969 (major/major vs. other genotypes). However, when we included only 
children with virus detections (N = 25) and compared rs1333969 CC (major/major) 
genotype to other genotypes, we detected 116 DEGs. Of these 116 DEGs, 105 (91%) 
were overexpressed, and 11 (9%) were under expressed in the CC (major/major) 
genotype. These DEGs were strongly associated with activation of the interferon 
pathway and immune responses against viruses. Gene set enrichment analysis 
showed that the most significant GO biological process was the “type I interferon 
signaling pathway” with 17/66 overlapping transcripts (P = 3.3 x 10-21). Interferon 
signaling was also the most significant pathway in the IPA (Ingenuity Pathway 
Analysis software, QIAGEN, Redwood City, CA, USA, 12/36 genes; P = 1.4 x  
10-18). 
In a similar analysis comparing rs273259 genotypes among children with virus 
detections, we detected 23 DEGs. Of these 23 DEGs, 19 (82%) were overexpressed 
and 4 (18%) were under-expressed in the AA (major/major) genotype (Figure 7). 
These DEGs included immune response related genes such as granulysin (GNLY) 
and granzyme A (GZMA). However, no statistically significant GO biological 
processes or IPA pathways were identified. When comparing DEGs associated with 
rs1333969 (N=116) and rs273259 (N = 23) genotypes, we found that 16 DEGs were 
identified in both comparisons (Figure 8). 
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Figure 7. Heatmap visualizing the expression levels of 24 probes targeting 23 differentially 
expressed genes (DEGs) between rs273259 AA (major/major) and other genotypes in 
children with viral detections (N=25). False discovery rate corrected P values of 0.05- 
and 1.25- fold change were used as cut-offs to detect DEGs. Expression values are log2 
transformed and normalized to median of the class “other genotype” (including AG 
[major/minor] and GG [minor/minor] genotypes). Samples are clustered using 
hierarchical clustering and Euclidean distance and colored according to rs273259 
genotype: AA (major/major)=green; AG(major/minor)= grey; GG (minor/minor) 
magenta. DEG, differentially expressed gene  
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Figure 8.  Venn diagram presenting the number of differentially expressed and overlapping genes 
in children with different genotypes of rs1333969 and rs273259 polymorphisms. 
Differential expression analysis was performed comparing major/major genotype to 
other genotypes (major/minor and minor/minor). False discovery rate adjusted P values 
.05- and 1.25- fold change were used as cut-offs for differentially expressed genes. 
5.5 Gene variants of innate immunity and RRIs 
5.5.1 The association between genetic variants of the innate 
immune system and RRIs 
Of the 1262 children, whose mothers had responded to the questionnaires on child 
health at the child’s ages of 12 and 24 months, 990 subjects (78.4%) provided a cord 
blood sample with successful genotyping. Children with RRIs (N = 96; 9.7% of the 
990 subjects) were identified by maternal answers to a question, “Has your child had 
recurrent infections” (yes/no). Of the RRI group, 27/96 (28.1%) responded yes to the 
12-month questionnaire, 56/96 (58.4%) responded yes to the 24-month questionnaire 
and 13/96 (13.5%) responded yes to both questionnaires. The remaining study 
population with successful genotyping from cord blood (N = 894/90.3%) was 
regarded as the comparison group. In contrast with the general population 
comparison group, the children with reported RRIs had more than five respiratory 
infections before one year of age (31% vs. 4%), more than five antibiotic treatments 
before two years of age (69% vs. 12%), and more often had tympanostomy tubes 
inserted (42% vs. 1%). As expected, based on Study I, from the partially overlapping 
population, RRI status was related to prenatal symptoms of depression (EPDS total 
sum score, P = 0.009) and pregnancy-specific anxiety (PRAQ-R2 total sum score, P 
= 0.028) but not to general anxiety symptoms. 
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The IL6 (rs1800795) variant was associated with an elevated risk for RRIs (aOR 
1.55; 95% CI, 1.14-2.12; P = 0.006, adjusted for sex) (Table 10). Other studied SNPs 
in innate immune genes were not significantly associated with increased or decreased 
risk for RRIs. Two polymorphisms in the interferon pathway participating gene 
IFI44L, rs1333969 (aOR 0.71; 95% CI, 0.50-1.01; P = 0.058) and rs273259 (aOR 
0.74; 95%CI, 0.53-1.02; P = 0.070) appeared as protective of RRIs. For the variant 
forms of MBL, the adjusted OR for RRIs was 1.28 (95% CI, 0.83-1.97). In MBL2 
gene, the most common coding allele was labelled as "A," and the three variants 
were collectively labelled as "O." Variants selected for this study were rs1333969 
and rs273259 at IFI44L; rs1990760, rs35667974, and rs3747517 at IFIH1; 
rs2243250 at IL4, rs1800795 at IL6; rs1800896 at IL10; rs2275913 at IL17A; 
rs5030737, rs1800450, and rs1800451 at MBL2; rs4986790 at TLR4; rs5743708 at 
TLR2; and rs361525 and rs1800629 at TNF (Table 10). 
Table 10. The association between single nucleotide polymorphism of innate immune genes and 
risk for recurrent respiratory infections. 
Gene Reference 
SNP 
MAF N FUNCTIONAL 
CONSEQUENCE 
OR (95%CI) P value 
IFI44L rs1333969 0.26 990 intron variant 0.71 (0.06–0.50) 0.058 
IFI44L rs273259 0.36 982 missense variant 0.74 (0.53–1.02) 0.070 
IFIH1 (MDA5) rs1990760 0.41 990 missense variant 1.03 (0.77–1.40 0.83 
IFIH1 (MDA5) rs35667974 0.02 990 missense variant 1.01 (0.31– 3.27) 0.99 
IFIH1 (MDA5) rs3747517 0.31 990 missense variant 0.82 (0.59–1.14) 0.24 
IL4 rs2243250 0.32 980 upstream gene variant 0.92 (0.67–1.27) 0.62 
IL6 rs1800795 0.46 976 intron variant 1.55 (1.14–2.12) 0.006 
IL10 rs1800896 0.45 990 upstream gene variant 1.00 (0.75–1.35) 0.98 
IL17A rs2275913 0.44 898 upstream gene variant 0.98 (0.72–1.33) 0.88 
MBL rs5030737 0.06 990 missense variant    
MBL rs1800450 0.13 990 missense variant 1.28 (0.83–1.97) 0.26 
MBL rs1800451 0.005 990 missense variant 
  
TLR4 rs4986790 0.10 990 missense variant 0.83 (0.50–1.41) 0.49 
TLR2 rs5743708 0.03 957 missense variant 1.18 (0.49–2.84) 0.72 
TNF rs361525 0.02 990 upstream gene variant 1.18 (0.45–3.08) 0.73 
TNF rs1800629 0.15 990 upstream gene variant 0.75 (0.47–1.18) 0.21 
Tested with the logistic regression analysis implemented with PLINK (Purcell) and adjusted for sex. 
N= number of genotyped children. Mainor allele frequency (MAF), Odds Ratio (OR) for recurrent 
respiratory infections, single nucleotide polymorphism (SNP). 
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5.5.2 IL6 and IFI44L genetic variants x prenatal maternal 
stress interaction 
As expected based on our earlier study from the partially overlapping population 
(Study I), RRI status was related to maternal total symptom scores of the EPDS and 
PRAQ-R2 questionnaires at gwks 34. For the GxE interaction analyses, IL6 and 
IFI44L polymorphisms were selected, because the association between IL6 genetic 
variants and RRIs was significant and between IFI44L variants and RRIs nearly 
significant. The population was categorized into minor/minor, major/minor and 
major/major genotypes of rs1800795, rs1333969 and rs273259 (Table 11). No 
interactions were identified, when continuous sum scores of the EPDS and PRAQ-
R2 were applied or when the children were categorized into two groups: 1) been born 
to a mother with clinically relevant scores on a depression/ pregnancy-specific 
anxiety questionnaire or 2) been born to a mother with low scores on a depression/ 
pregnancy-specific anxiety questionnaire (Table 11). 
Table 11.  Exposure to prenatal maternal psychological distress and genotype interaction logistic 
regression models. Odds Ratios, 95% Confidence Intervals and P values for the 
interaction terms. 
EPDS/PRAQ-R2 scores at gwks 34a-genotypeb N OR 95% CI P 
EPDS scores high - IL6 (rs1800795)  893 1.24 0.56–2.73 0.60 
PRAQR2 scores high - IL6 (rs1800795)  894 1.15 0.61–2.16 0.67 
EPDS scores high - IFI44L (rs1333969) 905 1.15 0.43–3.11 0.78 
PRAQR2 scores high - IFI44L (rs1333969) 906 1.62 0.77–3.42 0.20 
EPDS scores high - IFI44L (rs273259) 904 0.62 0.24–1.61 0.32 
PRAQR2 scores high - IFI44L (rs273259) 905 1.31 0.67–2.54 0.43 
a) The stress scores were categorized. The Edinburgh Postnatal Depression Scale (EPDS): <10 
points = Low (the reference category); ≥ 10 points = High. Pregnancy-Related Anxiety 
Questionnaire–Revised2 (PRAQ-R2): < 26 points = Low (the reference category); ≥ 26 points = 
High. b) Additive Model: major/major allele = 0, minor/major allele = 1 and minor/minor allele = 2. 
Finally, we addressed sex differences and performed post hoc analyses in children 
having in utero exposure of maternal psychological distress and children without in 
utero exposure psychological distress, separately for boys and girls, including the 
IL6 (Rs1800795) polymorphism. These analyses showed a significant association 
for the risk for recurrent infections (OR 1.96; 95% CI, 1.04-3.67, P = 0.04) in boys 
carrying the G-allele and born to mothers with high scores in the dichotomized 
pregnancy-specific anxiety questionnaire. In a small group of N = 75 mothers with 
clinical depression during late pregnancy, boys had increased risk for RRIs (OR 
1.95; 95% CI, 0.65-5.81, P = 0.23), but this observation lacked statistical power.  The 
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risk for RRIs was greater among girls born to mothers with low scores in the 
pregnancy-specific anxiety questionnaire and to mothers with clinical depression, 
but the findings were not significant (Table 12).  
Table 12.  How the IL-6 genotype was associated with the risk for RRIs after exposure to prenatal 
maternal psychological distress. Studied separately for boys and girls. 
IL6 (rs1800795)a-EPDS/PRAQR2 scoresb N OR 95%CI P value 
Boys  
  
 
PRAQR2 scores low 317 1.17 0.68–2.01 0.58 
PRAQR2 scores high 152 1.96 1.04–3.67 0.04 
EPDS scores low 394 1.40 0.90–2.16 0.13 
EPDS scores high 75 1.95 0.65–5.81 0.23 
     
Girls  
  
 
PRAQR2 scores low 310 1.83 0.97–3.44 0.06 
PRAQR2 scores high 114 1.23 0.58–2.61 0.59 
EPDS scores low 354 1.57 0.90–2.75 0.11 
EPDS scores high 69 1.69 0.66–4.34 0.28 
a) Additive Model: major/major allele = 0, minor/major allele = 1 and minor/minor allele =2. b) The 
maternal prenatal psychological distress scores were categorized. The Edinburgh Postnatal 
Depression Scale (EPDS): <10 points = Low (the reference category); ≥ 10 points = High. 
Pregnancy-Related Anxiety Questionnaire–Revised2 (PRAQ-R2): < 26 points = Low (the reference 
category); ≥ 26 points = High. Odds Ratio (OR) for recurrent respiratory infections. 
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6 Discussion 
6.1 Novel risk factors for respiratory infections: 
Prenatal maternal psychological distress and 
IFI44L and IL6 gene polymorphisms 
In Study I, the symptoms of maternal depression and anxiety and declined marital 
satisfaction at the end of pregnancy were associated with RRIs in children. It has 
been established before that families are burdened with the child's RRIs and  their 
parents’ experience psychological distress (Louhi-Pirkanniemi et al., 2004). A 
novelty in our study was that maternal psychological distress was measured during 
pregnancy, before the child was born. The fact that maternal psychological distress 
was an independent risk factor for RRIs after adjusting for other important 
environmental risk factors place our results in the context of fetal programming 
supporting maternal prenatal stress effects on the development of the child’s immune 
system. Mothers of the future RRI-group children reported during late pregnancy 
more symptoms of depression, pregnancy-specific anxiety, anxiety and lower levels 
of parental relationship satisfaction than mothers in the comparison group. This can 
be considered as notable source of psychological distress. A greater number of 
siblings and shorter duration of breastfeeding were also risk factors for child’s RRIs, 
which is in line with previous studies (Nokso-Koivisto et al., 2002; Toivonen et al., 
2016a). Children in the Study I were, to some extent, more often first-borns as 57% 
of the mothers were primiparous. 
Previous work regarding maternal prenatal stress and alterations of child’s 
immune system suggests that different forms of prenatal stress may have different 
outcomes. Sources of prenatal maternal stress according to studies have been major 
life events, for example, death of a close relative, natural catastrophes, daily hassles, 
poor relationship satisfaction, symptoms of depression, anxiety or pregnancy- 
specific anxiety. In order to standardize prenatal stress exposure, validated 
questionnaires on poor relationship satisfaction, symptoms of depression, anxiety or 
pregnancy-specific anxiety would help to compare results and enable repeated 
studies. The timing of the prenatal exposure should be taken into account, as previous 
studies suggest windows of vulnerability in fetal programming. Very early stages of 
development have been considered to be the most vulnerable time frame, but in our 
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Studies I and IV the association between maternal psychological distress and a 
child’s RRIs were found during the third trimester. 
In addition to environmental risk factors, the child's own characteristics affect 
the susceptibility to RRIs. Part of this variance can be explained by genetic variants, 
essentially through single nucleotide polymorphisms. In two prospective birth cohort 
studies (the STEPS study and the FinnBrain Birth Cohort Study), we analyzed the 
effect of two common single nucleotide polymorphisms in the type I interferon 
pathway gene IFI44L on children’s susceptibility to RTIs. The function of several 
interferon stimulated genes with potential antiviral action is unclear. In the FinnBrain 
Birth Cohort Study, the minor alleles of rs273259 and rs1333969 were associated 
with a decreased RTIs and antibiotic treatments frequency during the first year of 
life. In the STEPS study cohort, the minor G allele of rs273259 and minor T allele 
of rs1333969 were associated with a small decrease in the number of days with RTI 
symptoms per year and with a decrease in the rate of AOM before the age of two 
years. The FinnBrain Cohort was followed less intensively as only RTIs for which a 
visit to a physician was needed were recorded. In the STEPs study, only 41% of RTIs 
necessitated a physician visit. This partly explains the different relationships 
observed between respiratory tract infection frequency and IFI44L gene variants in 
the two Cohorts. The association of minor alleles of IFI44L with a lower rate of 
antibiotic use suggests that these polymorphisms protect against more severe RTIs. 
These findings suggest that proper levels of IFI44L, being not too high or low, are 
important. This regulation may have an effect on later complications leading to, for 
example, acute otitis media. In mRNA analyses, notably, differences were seen only 
in children who were positive for a respiratory virus. Compared to children with 
major/major genotype, children with major/minor or minor/minor genotypes had 
weaker transcriptional activity of IFI44L and, also, in expression of other IFNs 
signaling pathway genes.  
Although genetic variants of innate immunity and risk for RTIs have been 
studied before, there are only a few studies on genetic variants and RRIs (Westra et 
al., 2014; Toivonen et al., 2017; Nokso-Koivisto et al., 2014). In Study IV, we show 
an association between IL6 polymorphisms and risk for RRIs during the first two 
years of life in a partly overlapping population of Study I. The IL6 gene is located at 
the chromosome 7p21–24 locus with a 303bp promoter (Fishman et al., 1998). The 
polymorphism is located within the promoter region of the gene and influences 
transcriptional regulation and plasma IL-6 levels. It has been established with larger 
samples that the C allele is associated with significantly lower levels of plasma IL-6 
(Fishman et al., 1998). The association between psychological distress and RTIs 
could be mediated by IL-6. In adults, psychological distress predicts elevated IL-6 
levels in response to an upper respiratory infection with greater severity of symptoms 
(Cohen et al., 1999). IL-6 release is suggested to be partly mediated by 
Laura Korhonen 
 60
glucocorticoids, as almost all immune cells have glucocorticoid receptors. In 
addition, IL-6 has been shown to stimulate the adrenocortical axis showing bi-
directional communication between the HPA axis and immune system (Dobbs et al., 
1996; Bailey et al., 2003). IFNs are also sensitive to glucocorticoid regulation 
(Shodell and Siegal, 2001). The associations between IFI44L polymorphisms 
(rs1333969 and rs273259) and a child’s RRIs were close to the significance level in 
Study IV. The  IL6 -174 CC genotype  has been found to be a protective factor against 
childhood asthma (Li et al., 2015). A defective interferon response has been 
previously shown to be in relation to asthma (Durrani et al., 2012). More chronic 
proinflammation of the lung and airway may predispose to RRIs and the 
development of asthma. The susceptibility to RRIs and asthma may share common 
immunological pathways.  
6.2 HPA axis as a mediating mechanism between 
maternal psychological distress and respiratory 
infections 
Development of the HPA axis of the fetus and offspring plays a very important role 
for the child's subsequent susceptibility to infection. Lymphoid organs, and 
particularly the thymus, display a markedly elevated expression of glucocorticoid 
receptors during extra-uterine life (Merlot et al., 2008). In transgenic mice with 
impaired glucocorticoid function, an important role of glucocorticoids in the 
ontogeny of the immune system has been demonstrated (Sacedón et al., 1999). 
Maternal psychological distress and the associated high levels of cortisol convey 
information to the fetus about future environmental demands. According to the fetal 
programming theory, the fetus or newborn responds to adverse conditions by making 
developmental changes that are likely to increase survival and resilience in the 
expected environment (Bateson et al., 2004). If the environment matches the fetal 
programming, there are few effects on the future health of the child. However, a 
mismatch between actual environment and experience with fetal programming 
would increase the risk of illness (Avitsur et al., 2015). Study II was the first human 
study to investigate associations between prenatal psychological distress exposure 
and early infant HPA axis reactivity, when a concurrent rhinovirus infection that 
challenged the immune system was present. Interestingly, we found that after the 
preceding prenatal psychological distress exposure, the rhinovirus-positive infants 
had a blunted cortisol response in the stress test in comparison with their non- 
psychological distress exposed and psychological distress exposed counterparts. 
This association was more clearly seen in boys than in girls in analyses stratified by 
sex. Virus infection activates the systemic stress response. With infectious stressors, 
immune activation precedes, and glucocorticoids start to shape and restrain the 
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immune response. Studies have shown that normal glucocorticoid levels help 
mediate immune activation, whereas stress-induced glucocorticoid elevations begin 
to suppress the same activation later on in life (Dhabhar et al., 2012;McEwen, 2018). 
If the HPA axis has impaired function, then alterations in anti-viral immune 
responses may take place (Bailey et al., 2003; Webster and Sternberg, 2004). We can 
hypothesize that in our study, rhino-positive male infants were more prone to 
prolonged inflammation, as they failed to have an accurate HPA axis response to 
virus challenge. Both maternal prenatal stress and early rhinovirus wheezing illness 
have been linked to childhood asthma. The consensus has been that rhinovirus does 
not cause asthma in a straight-forward manner, but rather brings up a child's 
underlying vulnerability trait of an altered immune response (Lukkarinen et al., 
2017).  
In response to viral infection, activation of innate and adaptive immunity is 
required to limit the virus shedding and to stop viral replication. Pro-inflammatory 
cytokines induced during viral infection activate the HPA axis. For example, IL6 and 
IFNs are sensitive to glucocorticoid regulation. In addition to the traditional view of 
glucocorticoids as immunosuppressant hormones, an acute stress-induced rise of 
cortisol and adrenalin actually helps the immune system to respond to a pathogen 
(Dhabhar et al., 2012). HPA axis function and glucocorticoids do have 
immunomodulatory capacity that can both stimulate as well as suppress immune 
function (McEwen, 2018). Children in the RRI-group had exposure to maternal 
prenatal psychological distress and significantly more respiratory infections and 
antibiotic treatments before two years of age compared to the general 
population/comparison group. These findings suggest that children in the RRI-group 
can have altered immune responses to viral infections and susceptibility to later 
complications, such as AOMs. Animal and human studies suggest that alterations in 
HPA axis function affect the function or/and development of child immune system 
towards proinflammatory state. Moreover, high acute-phase cytokine producers 
from various cytokine polymorphisms may be susceptible to recurrent otitis media 
infections by different mechanisms (Revai et al., 2009). Children in the RRI group 
took significantly more antibiotics even before one year of age compared to the 
comparison group in both Studies I and IV. The strongest evidence of recurrent ear 
infections in the RRI-group in the Studies was the number of children that had 
tympanostomy tubes inserted as demonstrated in Study I (RRI group = 59% vs. the 
comparison group = 4%) and Study IV (RRI group = 42% vs. the comparison group 
= 1%). 
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6.3 Gene-environment interaction: Prenatal 
maternal psychological distress and the IL6 
gene polymorphism 
Mothers of children in the RRI group in Study IV had more symptoms of depression 
and pregnancy-specific anxiety during pregnancy, but the interaction models 
exploring the effect of prenatal maternal psychological distress to risk for recurrent 
infections in children with IL6 and IFI44L polymorphisms did not show increased 
risk for RRIs. This is in line with previous work of Andersson et al. suggesting that 
the prenatal maternal psychological distress influences immune development 
independently of genetic predisposition (Andersson et al., 2016). 
Pregnancy-specific anxiety can be considered as a specific component of 
prenatal psychosocial stress and has been found to be a powerful predictor of child 
health outcomes (Beijers et al., 2010; Beijers et al., 2014). Our observation that the 
analyses conducted separately by child’s sex yielded different results for boys and 
girls is suggestive of potential gender differences in GxE vulnerability for RRIs.  As 
shown in earlier GxE studies, sensitivity to environmental risk factors for a disease 
can be inherited instead of the disease itself. It has been shown before that the effects 
of in utero psychological distress  exposure on HPA axis function is different for 
male and female offspring and that these effects depend on the timing of in utero 
exposure to maternal distress at least for female offspring (Giesbrecht et al., 2017). 
In our study, maternal pregnancy-specific anxiety was associated with an increased 
the risk for RRIs in male offspring carrying the rs1800795 G-allele in a subgroup of 
high maternal prenatal psychological distress exposure that was in the highest 25th 
percentiles of PRAQ-R2 scores. In a small group of N = 75 mothers with clinical 
depression during late pregnancy, boys had a high risk for RRIs in association with 
IL6 G allele, whereas the risk was low in boys of mothers without depression. 
Regarding girls, such findings were not seen. 
6.4 Strengths and Limitations 
The data on child health and identification of the recurrent RTIs group were based 
on maternal reports. Studies have shown that mothers experiencing elevated levels 
of stress are more likely to seek medical treatment for minor symptoms that could 
be treated at home (Horwitz et al., 1993; Louhi-Pirkanniemi et al., 2004). A recent 
study suggested that particularly prenatal maternal anxiety — both general anxiety 
and pregnancy-specific anxiety — were important predictors of almost all aspects of 
parenting stress later in life (Huizink et al., 2017). In the STEPS study, regarding the 
children with RRIs, 60% were diagnosed with at least 3 episodes of AOMs and 73% 
of children with RRIs received at least 3 antibiotic treatments before the age of two 
years (Toivonen et al., 2016a). In our RRI group, the majority of children had more 
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than 5 antibiotic treatments before the age of two years. This gives some validation 
to our findings, because the fact that our RRI group clearly differed from the control 
group in antibiotic treatments and insertion of tympanostomy tubes indicates that the 
maternal report actually depicts children with exceptionally high rates of RTIs. Also, 
the maternal report reflects importance of child’s RRIs for the family. 
In Study II, the number of infants in the subgroups was low due to recruitment 
challenges. As for generalizability of the results, it is noteworthy that the relationship 
between prenatal psychological distress and HPA axis responses may depend on 
infant age, sex and/or the nature of the stressor (Giesbrecht et al., 2017; Tollenaar et 
al., 2011). In our study, during the research visit, there were three types of stressors, 
namely a standardized pediatric examination was performed by a venipuncture and 
a nasal swab with each being a source of mild physical discomfort. While again, the 
concurrent rhinovirus infection can be considered as a natural stressor challenging 
the HPA axis functioning. 
In Study III, the clinical outcomes were partly different between the two cohorts, 
and in the FinnBrain Cohort the follow-up was not as detailed as in the STEPS Study. 
However, the number of the antibiotic treatments and RTIs are   similar in both 
cohorts and the associations between IFI44L polymorphisms and antibiotic use as 
well as frequency of RTIs support the findings in both cohorts (Korhonen et al., 
2019; Toivonen et al., 2016a). Finnish people are a homogeneous genetic population 
of Caucasian origin, and as in all genetic association studies, corresponding data 
from other populations would be informative. 
In Study IV, the outcomes of RRI group were based on maternal report, which 
resulted in some inaccuracy in characterization of the phenotype. Another limitation 
was that the findings on differences between sexes were based on post hoc analyses. 
The main strengths of this work are the prospective design and relatively large 
sample size without any major exclusion criteria. This general population-based 
study allowed us to test of independent samples for the variances of the normal 
distribution. As for measurement of maternal prenatal psychological distress, we 
used longitudinal measurements during pre- and postnatal periods with validated 
questionnaires. For example, in the Norwegian Mother and Child Cohort Study 
2015, they used a self-constructed measure for declined marital satisfaction 
(Henriksen and Thuen, 2015). Also, our questionnaires covered both depression and 
anxiety symptoms prenatally at three time points. Compared to previous studies, 
research on this topic has not focused on recurrent respiratory infections but on a 
broader scale of infections in children, including, for example, gastroenteritis or 
serious infections that required hospitalization (M Tegethoff et al., 2011; Beijers et 
al., 2010; Henriksen and Thuen, 2015; Nielsen et al., 2011).  
We had high quality of our biological samples including the saliva cortisol, virus 
PCR, cord blood for genotyping and whole blood samples for mRNA transcriptional 
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profiles. We were able to search for functional effects of IFI44L polymorphisms by 
global transcriptome analysis in children with or without a virus infection in Study 
III. In Studies II and IV, we were not able to measure the inflammatory response to 
the infectious challenge, which is a limitation.  
There is novelty in our finding in all of these Studies I, II, III and IV, as similar 
hypotheses have not been studied previously. Only some published papers have 
taken into account child sex, while studying biological susceptibility to infections, 
although a child’s sex contributes to physiological and anatomical differences that 
influence innate and adaptive immune function (Klein and Flanagan, 2016). The 
genetic basis of risk for diseases differs between males and females, that is, that 
disease phenotypes have sex-specific genetic architectures (Morrow and Connallon, 
2013). In our Studies II and IV, analyses were done separately for boys and girls and 
in Study III, analyses were adjusted by sex. 
6.5 Future perspectives 
Improving the understanding of individual and environmental risk factors for 
recurrent respiratory infections may lead to new prevention strategies. Such 
strategies would be needed to lower morbidity in children under the age of two and 
to reduce the use of antibiotics and heath care services including tympanostomy 
tubes insertions. Upper- and lower respiratory tract infections, AOMs, RRIs, 
bronchiolitis, wheezing and childhood asthma constitute a significant burden of 
disease for children, families and society. 
Previously established risk factors for RTIs and AOMs, namely a shorter 
duration of breastfeeding and parental smoking, coexist with maternal psychological 
well-being. In our studies, potentially novel modifiable risk factors were maternal 
symptoms of depression and anxiety as well as relationship satisfaction. 
Pediatricians should seek to address families with psychosocial problems during the 
pre- and postnatal periods. We should create interventions that would support the 
mother’s psychological well-being, and thus we could improve the health of the 
children. 
Social and psychological factors should be considered already during pregnancy 
and across the early postnatal period. Epigenetic changes following prenatal stress 
are associated with changes in the in utero environment related to high levels of 
maternal stress hormones or stress-related alterations in placenta function (Monk et 
al., 2016). These changes may in turn affect the development of immune organs and 
host responses to infection later in life (Merlot et al., 2008). Although it is thought 
that the epigenetic changes that occur during pregnancy are permanent, there is also 
evidence of their resolution. Parental care during the neonatal period was found to 
be particularly important to the development of the HPA axis in both humans and 
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animals (Avitsur et al., 2015). In rats, higher quality maternal care, as quantified by 
more maternal licking and grooming, alter stable epigenetic states through effects on 
specific intracellular signaling pathways (Weaver et al., 2014). Mechanisms behind 
prenatal maternal psychological distress and the development of immune-related 
disorders deserve further research. For example, could the suppression of HPA axis 
functions (observed in Study II) associate with later disease development, such as 
atopic disorders and wheezing or asthma? What are the time points for windows of 
vulnerability during the pre- and postnatal period and therefore best times for 
intervention?  
The host response to RTIs is unique, as some children have more severe and 
prolonged symptoms as well as more complications such as AOM and need more 
antibiotic treatments. Genetic variation of the innate immunity explains part of 
variance in the host response. When we better understand the pathogenesis of 
diseases and gather more information about genomes and phenotypes, in the future, 
there will be possibilities to have more targeted immunomodulatory treatments. We 
will be able to identify increased genotype-specific risk groups. Genes interact with 
the environment and in preventing diseases, GxE research is important for finding 
increased environment-specific risk for individuals with a particular genotype. 
Mainly animal studies, but also human studies have shown that there is resilience in 
immunity (Dantzer et al., 2018). Resilient individuals have a different immune 
phenotype than individuals that are vulnerable to stress. It could be possible to turn 
stress-susceptible individuals resilient and vice versa by changing their 
inflammatory phenotype. The resilient immune phenotype also influences the ability 
to recover from inflammation-induced symptoms. Bidirectional relationships 
between resilience and immunity by the gut microbiota open the possibility to 
influence them through probiotics and prebiotics (Dantzer et al., 2018). 
This thesis provides epidemiological support for creating new hypotheses for 
both intervention studies as well as experimental studies on the biological 
mechanisms behind the associations between maternal psychological distress and a 
child’s recurrent respiratory tract infections and other immune related disorders such 
as wheezing and asthma. Our work suggests that possible sex differences and an 
individual’s genetic traits should be considered when focusing on environmental risk 
factors and prenatal programming. 
 66
7 Conclusions 
This work suggests that maternal prenatal psychological distress potentially 
influences a child's susceptibility to RTIs. The HPA axis and its end-product cortisol 
are most likely the mediating mechanisms behind this association.  
1. Maternal symptoms of depression, anxiety, pregnancy-specific anxiety 
and declined relationship quality, after controlling for essential 
confounding factors, associated with recurrent respiratory infections in 
children up to two years of life. 
2. We observed a blunted cortisol response to a natural stressor, which was 
a concurrent subclinical rhinovirus infection, in children, whose mothers 
experienced psychological distress during pregnancy.    
3. IFI44L gene polymorphisms showed to be protective against RTIs and 
AOMs. Minor alleles associated with a weaker interferon response. Part 
of the unique host response to viral infections could be explained by 
genetic trait and single nucleotide variations.    
4. Prenatal maternal psychological distress influences on fetal programming 
can potentially explain a part of the non-genetic variability in immune-
related disorders. Our gene-environment study suggested that prenatal 
maternal psychological distress does play an independent role as a risk 
factor for RRIs. Among the studied genetic variants of innate immunity, 
polymorphisms in the IL6 gene could be a risk factor for RRIs. 
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